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Despite the regenerative capacity of skeletal muscle, chronic myopathy and muscle 
trauma present significant clinical problems with limited therapeutic options.  Myogenic cell 
therapies are being actively investigated to mitigate muscle degeneration that otherwise 
progresses to fibrosis and long-term loss of function.  The rationale for this strategy is based on 
augmenting or recapitulating the normal process of muscle regeneration by injecting myogenic 
progenitor cells into the injured muscle.  These exogenous progenitor cells may either fuse with 
the damaged myofibers or take up residence in an endomysial or satellite cell niche to be 
activated at some later date.  However, engraftment efficiency in myogenic cell transplantation is 
impaired by rapid cell death, which represents a precipitous loss of cell viability within the first 
two days following injection, therefore severely limiting engraftment and tissue regeneration.   
Upon transplantation, cells experience a host response of rapid inflammation; an 
environment of oxidative and inflammatory stress that causes a dramatic loss in cell viability.  
This effect may determine the regeneration capacity irrespective of the cell’s multilineage 
differentiation potential.  Our lab has isolated and characterized multiple populations of 
myogenic progenitors from murine and human skeletal muscle, including the muscle derived 
stem cell (MDSC) isolated by a modified preplate technique.  In our studies of MDSCs, we 
observed an increase in post-transplantation survival and skeletal muscle regeneration capacity 
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compared to myoblasts.  Furthermore, a strong correlation of improved survival and regeneration 
with inflammatory and oxidative stress resistance emerged.   
In this dissertation, we examined the role stress resistance and survival during myogenic 
differentiation of MDSCs.  By treating the transplanted cells with a membrane permeable 
reactive oxygen species scavenger, XJB-5-131, prior to transplantation, the survival and 
myogenic differentiation capacity under stress conditions was significantly improved.  
Furthermore, we isolated a novel sub-population of muscle derived cells with elevated stress 
resistance from murine and human skeletal muscle by their enhanced aldehyde dehydrogenase 
activity.  ALDHlo and ALDHhi cells were characterized in terms of their myogenic potential and 
stress tolerance in vitro and muscle regeneration capacity in vivo.  These studies are aimed at 
understanding the importance of survival and stress tolerance of transplanted cells in skeletal 
muscle cell therapy and how this tolerance modifies the efficacy of cell therapy. 
 
 
  vi 
TABLE OF CONTENTS 
PREFACE ............................................................................................................................... XVII 
1.0 INTRODUCTION ........................................................................................................ 1 
1.1 DUCHENNE MUSCULAR DYSTROPHY: A MODEL OF DEGENERATIVE 
MUSCLE PATHOLOGY .................................................................................................... 2 
1.2 PHYSIOLOGIC MECHANISM OF MUSCLE REPAIR:  ROLE OF 
SATELLITE CELLS AND OTHER MYOGENIC PROGENITORS ............................ 5 
1.3 MYOGENIC PROGENITORS FOR CELL THERAPY ........................................ 6 
1.4 CHALLENGES IN TRANSLATION OF MYOGENIC CELL 
TRANSPLANTATION ........................................................................................................ 8 
1.4.1 Acute immunogenicity of myogenic cell transplantation ............................. 9 
1.4.2 Limited migration of transplanted myogenic cells ...................................... 12 
1.4.3 Immune rejection of transplanted myogenic cells ...................................... 14 
1.4.4 Reactive oxygen species and antioxidant capacity of MDSCs ................... 14 
1.4.4.1 Calcium dysregulation and the mitochondria .................................. 17 
1.4.5 Aldehyde dehydrogenase: A marker for early progenitor status .............. 18 
1.5 SPECIFIC AIMS OF DISSERTATION ................................................................. 21 
1.5.1 Specific Aim 1: To elucidate the role of survival in myogenic 
differentiation capacity in vitro and in muscle regeneration capacity in vivo ..... 22 
  vii 
1.5.2 Specific Aim 2: To determine the muscle regeneration capacity of a sub-
population of murine preplate cells with elevated stress resistance ...................... 23 
1.5.3 Specific Aim 3: To determine the stress resistance and myogenic capacity 
of cultured human muscle derived cells with elevated aldehyde dehydrogenase 
(ALDH) activity .......................................................................................................... 24 
1.5.4 Tissue specimen acquisition and animal use ................................................ 24 
1.5.4.1 Human Subjects .................................................................................. 24 
1.5.4.2 Vertebrate Animals ............................................................................. 24 
2.0 SPECIFIC AIM 1:  ROLE OF CELL SURVIVAL IN MYOGENIC CAPACITY  
  ...................................................................................................................................... 26 
2.1 BACKGROUND ........................................................................................................ 26 
2.1.1 Myogenic cell transplantation is limited by poor cell survival .................. 26 
2.1.2 Increased stress resistance is associated with enhanced regeneration 
capacity ....................................................................................................................... 28 
2.1.3 Targeting mitochondrial reactive oxygen species to improve myogenic 
cells survival ................................................................................................................ 30 
2.2 RATIONALE ............................................................................................................. 31 
2.3 EXPERIMENTAL DESIGN .................................................................................... 33 
2.4 METHODS ................................................................................................................. 35 
2.4.1 Murine MDSC and myoblast isolation via the preplate technique ........... 35 
2.4.2 Survival and proliferation of myoblasts and MDSCs in DM ..................... 36 
2.4.3 Myogenic differentiation assays .................................................................... 37 
2.4.4 In vitro proliferation capacity ....................................................................... 37 
  viii 
2.4.5 In vitro myogenic differentiation capacity ................................................... 38 
2.4.6 Skeletal muscle regeneration capacity ......................................................... 38 
2.4.7 Statistical Analysis ......................................................................................... 39 
2.5 RESULTS ................................................................................................................... 40 
2.5.1 Proliferation and survival of myoblasts and MDSCs in differentiation 
media  .......................................................................................................................... 40 
2.5.2 Improved differentiation capacity of XJB treated cells in oxidative stress ..  
  .......................................................................................................................... 43 
2.5.3 Skeletal muscle regeneration capacity of XJB treated cells ....................... 45 
2.6 DISCUSSION ............................................................................................................. 46 
3.0 SPECIFIC AIM 2: TO DETERMINE THE MUSCLE REGENERATION 
CAPACITY OF A SUB-POPULATION OF MURINE PREPLATE CELLS WITH 
ELEVATED STRESS RESISTANCE ...................................................................................... 50 
3.1 BACKGROUND ........................................................................................................ 50 
3.1.1 Muscle derived stem cell isolation via a modified preplate technique ...... 50 
3.1.2 Elevated oxidative stress resistance of MDSCs ........................................... 51 
3.1.3 Aldehyde dehydrogenase as a marker for early progenitor status and 
enhanced stress resistance ......................................................................................... 52 
3.2 RATIONALE ............................................................................................................. 53 
3.3 EXPERIMENTAL DESIGN .................................................................................... 53 
3.4 METHODS ................................................................................................................. 55 
3.4.1 Murine myoblast and MDSC isolation via the preplate technique ........... 55 
3.4.2 Flow cytometric analysis and sorting by ALDH activity ............................ 55 
  ix 
3.4.3 In vitro proliferation capacity ....................................................................... 56 
3.4.4 In vitro muscle differentiation capacity ....................................................... 56 
3.4.5 Intracellular antioxidant capacity ................................................................ 57 
3.4.6 Skeletal muscle regeneration capacity ......................................................... 58 
3.4.7 Immunohistochemistry .................................................................................. 59 
3.4.8 Osteogenic and chondrogenic differentiation capacity ............................... 60 
3.4.9 Statistical Analysis ......................................................................................... 60 
3.5 RESULTS ................................................................................................................... 61 
3.5.1 Flow cytometric sorting of murine preplate cells ........................................ 61 
3.5.2 Enrichment of ALDHhi cells in slowly adhering preplate cells .................. 63 
3.5.3 Stress resistance of ALDH sorted myoblasts ............................................... 65 
3.5.4 Skeletal muscle regeneration capacity of ALDH sorted myoblasts ........... 67 
3.5.5 Mechanism of increased stress resistance in ALDHhi murine myoblasts . 69 
3.5.6 Chondrogenic and osteogenic differentiation of ALDH sorted myoblasts ...  
  .......................................................................................................................... 72 
3.5.7 Isolation and stress resistance of ALDH sorted MDSCs ............................ 74 
3.6 DISCUSSION ............................................................................................................. 79 
4.0 SPECIFIC AIM 3: ALDH ACTIVITY AS A MARKER FOR MYOGENIC 
CAPACITY AND STRESS RESISTANCE IN HUMAN MUSCLE DERIVED CELLS .... 83 
4.1 BACKGROUND ........................................................................................................ 83 
  x 
4.1.1 Aldehyde dehydrogenase as a marker for early progenitor status in 
human cells ................................................................................................................. 83 
4.2 RATIONALE ............................................................................................................. 86 
4.3 EXPERIMENTAL DESIGN .................................................................................... 86 
4.4 METHODS ................................................................................................................. 88 
4.4.1 Human muscle cell isolation .......................................................................... 88 
4.4.2 Flow cytometric analysis and sorting by ALDH activity ............................ 89 
4.4.3 In vitro proliferation capacity ....................................................................... 89 
4.4.4 In vitro muscle differentiation capacity ....................................................... 90 
4.4.5 Intracellular antioxidant capacity ................................................................ 90 
4.4.6 Skeletal muscle regeneration capacity ......................................................... 91 
4.4.7 Statistical Analysis ......................................................................................... 91 
4.5 RESULTS ................................................................................................................... 91 
4.5.1 Stress resistance of ALDH sorted hMDCs ................................................... 91 
4.5.2 Skeletal muscle regeneration capacity of ALDH sorted hMDCs............... 93 
4.5.3 Stress resistance capacity of the ALDH sorted hMDCs.............................. 94 
4.5.4 Osteogenic and chondrogenic differentiation potential of ALDH sorted 
hMDCs ........................................................................................................................ 96 
4.6 DISCUSSION ............................................................................................................. 97 
5.0 DISSERTATION CONCLUSIONS ....................................................................... 102 
6.0 OTHER RELATED PROJECTS ........................................................................... 105 
  xi 
6.1 THE ROLE OF ANOIKIS RESISTANCE IN ISOLATING MDSCS ............... 105 
6.1.1 Background ................................................................................................... 105 
6.1.2 Experimental design .................................................................................... 108 
6.1.3 Results ........................................................................................................... 109 
6.1.4 Discussion and future directions ................................................................. 111 
6.2 MEASURING MUSCULAR VASCULARITY USING MICRO X-RAY 
TOMOGRAPHY .............................................................................................................. 112 
6.2.1 Experimental design .................................................................................... 112 
6.2.2 Results ........................................................................................................... 113 
6.2.3 Discussion ...................................................................................................... 113 
BIBLIOGRAPHY ..................................................................................................................... 115 
  xii 
 LIST OF TABLES 
 
Table 1.  Human ALDH sorted skeletal muscle cells surface marker analysis186 ........................ 85 
  xiii 
LIST OF FIGURES 
 
Figure 1.  General reaction of aldehyde dehydrogenase197 ........................................................... 20 
Figure 2.  Schematic of major intracellular antioxidants .............................................................. 29 
Figure 3.  Experimental schematic of MDSC and myoblast survival during myogenic 
differentiation in vitro ................................................................................................................... 34 
Figure 4.  Experimental schematic to examine the regenerative capacity of anti-oxidant (XJB) 
treated muscle derived cells .......................................................................................................... 35 
Figure 5.  Increased rate of proliferation of MDSCs in oxidative and inflammatory stress ......... 40 
Figure 6.  Loss of proliferation capacity in myoblasts in low serum and stress conditions ......... 41 
Figure 7.  Survival of myoblasts and MDSCs in low serum media .............................................. 42 
Figure 8.  Additional loss in proliferative capacity of myoblasts in DM under oxidative stress 
conditions ...................................................................................................................................... 43 
Figure 9.  No additional loss in proliferative capacity of myoblasts in conditions of inflammatory 
stress .............................................................................................................................................. 43 
Figure 10.  Improved myogenic differentiation capacity of MDSC pretreated with antioxidant 
XJB ............................................................................................................................................... 44 
Figure 11.  Correlation of myogenic differentiation of MDSCs with survival ............................. 45 
Figure 12.  Skeletal muscle regenerative capacity of myoblasts and MSDCs with antioxidant 
pretreatment .................................................................................................................................. 46 
Figure 13.  Experimental schematic to study stress resistance capacity of ALDH sorted murine 
preplate cells ................................................................................................................................. 54 
Figure 14.  Experimental schematic to characterize the muscle regeneration capacity of ALDH 
sorted murine pre-plate cells ......................................................................................................... 54 
Figure 15.  FACS analysis of murine myoblasts and MSDCs ...................................................... 62 
Figure 16.  ALDH activity of murine muscle preplate cells via FACS ........................................ 63 
  xiv 
Figure 17.  ALDHhi muscle cells yield later preplate populations ................................................ 64 
Figure 18.  ALDH sorted myoblast proliferation in oxidative and inflammatory stress .............. 66 
Figure 19. Myogenic differentiation of ALDH sorted myoblasts in conditions of oxidative and 
inflammatory stress ....................................................................................................................... 67 
Figure 20.  Skeletal muscle regeneration capacity of ALDH sorted myoblasts ........................... 68 
Figure 21.  Intracellular anti-oxidant (GSH and SOD) levels of ALDH sorted myoblasts .......... 69 
Figure 22.  Anti-oxidant and pro-oxidant treatment of ALDH sorted myoblasts to elucidate the 
role of intracellular anti-oxidant levels on oxidative stress resistance ......................................... 70 
Figure 23.  ALDH inhibition by DEAB does not alter stress resistance behavior of ALDH sorted 
myoblasts ...................................................................................................................................... 71 
Figure 24.  Chondrogenic and osteogenic differentiation capacity of ALDH sorted myoblasts in 
vitro ............................................................................................................................................... 74 
Figure 25.  FACS isolation and proliferation capacity of ALDH sorted MDSCs in oxidative and 
inflammatory stress conditions ..................................................................................................... 75 
Figure 26.  Myogenic differentiation of ALDH sorted MDSCs in oxidative and inflammatory 
stress .............................................................................................................................................. 76 
Figure 27.  Skeletal muscle regeneration capacity of ALDH sorted MDSCs .............................. 77 
Figure 28.  Intracellular antioxidant levels (GSH and SOD) of ALDH sorted MDSCs ............... 78 
Figure 29.  Osteogenic and chondrogenic capacity of ALDH sorted MDSCs ............................. 79 
Figure 30.  ALDH+ myogenic progenitors isolated from human skeletal muscle ........................ 84 
Figure 31.  Experimental schematic to examine the stress resistance capacity of ALDH sorted 
hMDCs .......................................................................................................................................... 87 
Figure 32.  Experimental schematic to examine the muscle regenerative capacity of ALDH 
sorted hMDCs ............................................................................................................................... 88 
Figure 33.  FACS sorting of hMDCs on ALDH activity and ALDH sorted hMDC proliferation in 
oxidative and inflammatory stress ................................................................................................ 92 
Figure 34.  Myogenic differentiation of ALDH sorted hMDCs in oxidative and inflammatory 
stress .............................................................................................................................................. 93 
Figure 35.  Skeletal muscle regeneration capacity of ALDH sorted hMDCs ............................... 94 
Figure 36.  Intracellular anti-oxidant (GSH and SOD) levels of ALDH sorted hDMCs .............. 95 
Figure 37.  Reactive oxygen species accumulation in hMDCs during oxidative stress ............... 96 
Figure 38.  Osteogenic and chondrogenic differentiation capacity if ALDH sorted hMDCs in 
vitro ............................................................................................................................................... 97 
  xv 
Figure 39.  Experimental schematic to examine preplate survival of ALDH sorted murine muscle 
derived cells ................................................................................................................................ 108 
Figure 40.  Experimental schematic of to examine anoikis resistance cells for ALDH activity 109 
Figure 41.  Preplate survival of ALDH sorted murine muscle derived cells .............................. 110 
Figure 42.  Radio-opaque polymer casting of skeletal muscle vasculature ................................ 113 
  xvi 
 NOMENCLATURE AND ABBREVIATIONS 
ALDH  Aldehyde dehydrogenase 
ALP  Alkaline phosphatase 
bFGF  Basic fibroblast growth factor 
BMP-4  Bone morphogenic protein-4 
CDK  Cyclin dependent kinase 
Cy3   Cyanine 
DAPI  4',6-diamidino-2-phenylindole 
DEAB  Diethylaminobenzaldehyde 
DEM  Diethyl maleate 
DYS  Dystrophin 
DM   Differentiation media (2% serum) 
EP   Early preplate myoblast 
FACS  Fluorescence activated cell sorting 
FITC  Fluoroscien isothiocyanate 
FoxO  Forkhead family of transcription factors 
GAG  Glycosaminoglycan 
GSH  Glutathione (reduced) 
hMDC  Human muscle derived cell 
MDSC  Muscle derived stem cell 
MDC  Muscle derived cell 
mdx  Dystrophin null mouse 
MHC  Myosin heavy chain 
mPTP  Mitochondrial permeability transition pore 
MTT  Myoblast transfer therapy 
NAC  N-acetylcysteine 
NOX 2   Nicotinamide adenine dinucleotide phosphate oxidase 2 
NOS   Nitric oxide synthase 
PI   Propidium Iodide 
P/S   Penicillin/ Streptomycin 
Pmf   Proton motive force 
PM   Proliferation media (20% serum) 
PMN  Polymorphonuclear cell (neutrophil) 
Rb   Retinoblastoma protein 
ROS  Reactive oxygen species 
RNS  Reactive nitrogen species 
SCID  Severe combined immunodeficiency 
SOD  Superoxide dismutase 
TGF-β3  Transforming growth factor- beta3 
TNF-α  Tumor necrosis factor-alpha 
  xvii 
PREFACE 
Acknowledgements: 
This dissertation is dedicated to my family:  to my wife Karyn who soldiered with me 
through every peak and valley of this process: writing off countless weekends so I could tend to 
cells in culture or to mice whose timepoints had come.  To Middy and Caitlin, two of the most 
beautiful little girls this side of the Allegheny, who have a special gift for erasing any memory of 
a long day with a well-timed hug or silly joke told loudly, wide-eyed, and with hands flying. 
To my advisor, Johnny Huard, who decided to take on a Materials Engineer with exactly 
zero experience in cell biology.  I am grateful for his leap of faith to allow me to learn and 
struggle and persevere and finally to create this dissertation.  I’ll never forget revising an ORS 
podium presentation with Johnny in New Orleans five minutes before I was scheduled to speak.  
The crescendo of nervous energy and Johnny’s infectious excitement propelled me through any 
fear of flubbing fantastically in front of a few hundred of my future colleagues.  At the frontier of 
research or on the precipice of a hard deadline, Johnny is at his best.  I am also grateful for the 
support and insight of my committee members Profs. Piganelli, Li, and Roy.  I would be remiss 
if I didn’t recognize the encouragement of Jim Cummins and Burhan Gharaibeh who were 
relentlessly supportive of my efforts throughout my years in the Huard lab. 
There were many people that contributed to the work described in this dissertation.  Ken 
Urish was not only the first student that I met at Pitt but he initiated me in nearly every technique 
that I employed in this project.  I have him to thank and getting me started in the Huard lab and 
in muscle regeneration research.  Mark Bucsek worked tirelessly on proliferation assays, 
bioreactor experiments, and staining of tissue and cells and is now on his way to his own career 
in biomedical research.  Minjung Song is primarily responsible for the osteogenic and 
chondrogenic assays completed for this project.  Alison Logar and Lynda Guzik were critical in 
teaching me about flow cytometry and sorting my cell populations. 
  1 
1.0  INTRODUCTION 
Muscle injury can result from insults that range from mechanical overloading, traumatic injury, 
metabolic disorders, ischemic events, and congenital dysfunction.  Often these insults exceed the 
body’s capacity to regenerate functional muscle.  Cell therapies, in which myogenic progenitors 
are transplanted to the muscle to promote regeneration, remain a promising field of regenerative 
medicine.  The field witnessed dramatic advances during the past two decades in the form of 
myoblast transfer therapy (MTT) primarily for the treatment of Duchenne Muscular Dystrophy 
(DMD).  DMD is the most common (1/3500 live male births) and severe of the congenital 
muscular dystrophies1. It is an X-linked muscle disease characterized by progressive muscle 
weakness due to the lack of dystrophin expression at the sarcolemma of muscle fibers2-6. The 
lack of dystrophin in skeletal muscle disrupts the linkage between the subsarcolemmal 
cytoskeleton and the basal lamina, resulting in muscle fiber necrosis and progressive muscle 
weakness7,8.   
 Although researchers have extensively investigated various approaches to deliver 
dystrophin in dystrophic muscle (for example, cell and gene therapy), there is still no efficient 
treatment that alleviates the muscle weakness caused by DMD.  Transplantation of normal 
myoblasts into dystrophin-deficient muscle can create a reservoir of normal myoblasts capable of 
fusing with dystrophic muscle fibers and restoring dystrophin9-33.  Although myoblast 
transplantation can transiently deliver dystrophin and improve the strength of dystrophic muscle, 
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clinical trials of this approach yielded various limitations, including immune rejection, poor cell 
survival rates, and the limited spread of the injected cells9-32. 
 Isolation of muscle cells that can overcome these limitations would enhance the success 
of myoblast transplantation significantly.  In this introduction, I briefly review the 
immunological issues and transplanted cell phenotypes that affect the efficacy of cell mediated 
transplantation. However, special attention is given to the transplanted cell’s ability to withstand 
inflammation and the deleterious effects of oxidative and inflammatory stress.  
1.1 DUCHENNE MUSCULAR DYSTROPHY: A MODEL OF DEGENERATIVE 
MUSCLE PATHOLOGY 
In addition to its contractile function, skeletal muscle is designed to withstand and adapt to 
repeated cycles of mechanical loading throughout our lifetime.  This loading exposes the tissue 
to injury that induces regeneration without any functional loss.  In fact muscle regeneration in 
this context often induces functional gain.  This normal process of injury and regeneration 
follows a common pattern of interplay between the injured muscle fibers, resident and infiltrating 
immune cells, and the satellite cells that are primarily responsible for skeletal muscle 
regeneration.  However pathologic muscle injury from insults such as traumatic injury, metabolic 
disorders, ischemic events, and genetic dysfunction may not always result in functional 
regeneration due to the severity of the insult or the compromised ability of the host to regenerate 
the damaged tissue. 
One prominent model of chronic muscle degeneration is Duchenne Muscular Dystrophy, 
a devastating dystrophinopathy characterized by progressive muscle weakness and wasting due 
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to familial or spontaneous dystrophin gene mutations2-6,34. Dystrophin is a structural protein that 
concentrates at the myocyte z-line and forms a mechanical link between cytoplasmic actin and 
the basal lamina via a membrane bound dystrophin associated complex.  In this way dystrophin 
transfers the force of contraction to the basal lamina7,8,35.  In its absence each contraction exposes 
the myocyte to membrane tearing, loss of cellular potential, and calcium ion leakage which 
initiates a cascade of cell necrosis, inflammation and satellite cell activation36.  Similar acute 
events of membrane tearing that occur during normal muscle loading should trigger regeneration 
with no loss of strength or satellite cell reserve.  However, in DMD this process is widespread, 
ongoing and ultimately overwhelms the muscle’s native capacity for repair.  This disorder 
ultimately leads to cardiomyopathy, prominent kyphosis, and diaphragmatic and respiratory 
dysfunction.  Current medical intervention is primarily supportive and targets delay of 
symptomatic progression37-39. Death results from respiratory insufficiency, pulmonary infection, 
and cardiac decompensation in the third decade of life35,38. 
Considerable research effort has been devoted to efficient delivery of dystrophin to 
dystrophic muscle through various means such as cell and gene therapy, however challenges 
remain before clinical translation can be realized.  While transplantation of normal myoblasts or 
other myogenic cells into dystrophin-deficient muscle can create a reservoir of normal myoblasts 
capable of fusing with dystrophic muscle fibers and restoring dystrophin, this approach has 
important limitations, which include immune rejection, poor cell survival rates, and restricted 
spreading of the injected cells9-32. 
The concept of loss of muscle progenitor reserve in the context of chronic muscle 
degeneration continues to motivate research into the efficacy of myogenic cell transplantation to 
augment or replenish this reserve.  That is, the satellite cell reserve is unable regenerate at the 
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same rate as the ongoing process of degeneration.  However, perhaps the pathology of 
degenerative muscle disorders could be alleviated by replenishing the progenitor cell reservoir by 
allo- or autogenous transplantation of myoblasts.  Furthermore, myoblasts could be genetically 
modified prior to transplantation to correct genetic disorders such as DMD, perhaps halting the 
ongoing pathology.  Despite the isolation of numerous myogenic cell candidates, this cell 
therapy has so far proved elusive in DMD.  One the most severe limitations is the high rate of 
cell death (up to 99%) within the first 48hrs of injection9-32.  Researchers continue to explore 
explanations for this acute loss and to study methods to increase survival during this critical 
period40.  It is encouraging to note however that the subpopulation of cells that do survive this 
initial period go on to fuse to existing myofibers and appear to trigger myofiber regeneration and 
promote angiogenesis in a paracrine fashion41-43. 
Acute cell loss on transplantation appears to stem from a complex immune response to 
several simultaneous events including: the tissue damage of the injection and pro-inflammatory 
activity of host and even donor myoblasts44,45.  It may even involve local ischemia due to 
disruption of capillary hemodynamics commonly seen in ischemia/reperfusion injury which 
generates numerous reactive oxygen species46. The cause of this precipitous loss of transplanted 
cells is not entirely resolved.  The temporal profile of the response suggests activity from the 
innate immune system including inflammation and the influx of activated neutrophils47, 
macrophages48,49, and natural killer (NK) cells50,51.  The injected cells are likely exposed to a 
storm of reactive oxygen species (ROS) and inflammatory cytokines.  Recent studies have shown 
that the cells that do survive and engraft also have increased oxidative and inflammatory stress 
tolerance43,52. 
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1.2 PHYSIOLOGIC MECHANISM OF MUSCLE REPAIR:  ROLE OF SATELLITE 
CELLS AND OTHER MYOGENIC PROGENITORS 
The fundamental cellular unit of skeletal muscle is the myofiber, a linear, multi-nucleated cell 
whose contractile actin-myosin machinery is distributed serially along the length of the fiber.  
During contraction these actin-myosin networks induce radical dimensional changes of the cell 
and therefore considerable shear strains in the sarcolemma.  In cases of excessive loading or 
trauma, sarcolemmal tearing allows calcium ion leakage into the cytoplasm which can lead to 
myofiber necrosis facilitated by calcium dependent proteolysis  (e.g. via calpains) and increased 
mitochondrial ROS production.  Both events may trigger a cascade of acute immune cell 
activation, primarily of macrophages and neutrophils53-57.  While immune cell activation will 
initially promote further damage, it is critical for muscle regeneration with a particularly vital 
role for the macrophage36,58. 
Embedded in the basal lamina of myofibers are satellite cells, myogenic progenitors that 
are primarily responsible for post-natal skeletal muscle regeneration. Activated satellite cells 
divide asymmetrically to self-renew and yield a rapidly dividing population of myoblast daughter 
cells, which migrate to the site of muscle injury.  Myoblasts can either fuse with the damaged 
myofiber or with one another to form a new myofiber. In congenital myopathies such as 
Duchenne muscular dystrophy the satellite cell reserve may be depleted by chronic activation 
and oxidative damage from on going cycles of sarcolemmal rupture, necrosis, and immune cell 
activation59-61.  Furthermore, large muscle lesions induced by trauma or ischemia (e.g. 
compartment syndrome) can simply overwhelm the satellite cell reserve such that they were 
unable to recreate the gross muscle morphology required to restore muscle function. 
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Studies have shown that the satellite cell is not the only myogenic cell that can be 
activated to induce skeletal muscle regeneration.  Bone marrow derived cells (mesenchymal stem 
cell or marrow stromal cell) can differentiate into myoblasts or even enter the satellite cell 
position and undergo myogenesis at a later time62-64.  A number of multipotent progenitor cells 
have been isolated from muscle such as muscle derived stem cells42, side-population cells65, Sk-
DN/Sk-34 cells66, and CD133+ progenitors67,68.  There is growing evidence that these cells are 
intimately associated with or even share a common lineage with blood vessels69-71.  Indeed 
prospective isolation of pericytes72, mesangioblasts73, and myo-endothelial74 cells have yielded 
myogenic differentiation in vitro and in vivo74-76.  Given their multipotency, their ability to 
regenerate muscle may stem not only from their myogenic differentiation potential but their 
ability to promote nerve regeneration and angiogenesis in the context of cell transplantation, thus 
recapitulating a full complement of functioning muscle77,78. 
1.3 MYOGENIC PROGENITORS FOR CELL THERAPY 
Irrespective of their physiologic function, a multitude of myogenic cells have been isolated to 
date and have been shown to recapitulate myogenesis in vitro by fusing into syncytial and 
contractile myotubes.  More importantly, these cells when transplanted have demonstrated their 
ability to participate in skeletal and in many cases cardiac muscle regeneration45.  They do so 
either by fusion with existing myofibers, generation of new myofibers by fusing with each other, 
or stimulating regeneration in a paracrine fashion.  Therefore we have accumulated a virtual 
library of cells to study possible cell therapies for muscle degeneration.  Which of these cells 
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offer the greatest ease of isolation, greatest capacity for regeneration, and how they are related to 
one another are all active of areas of research45. 
Muscle derived stem cells (MDSCs) have been isolated by our lab from skeletal muscle 
using a modified preplate technique42,79.  Briefly, this technique involves enzymatically 
dissociating cells from excised muscle and isolating MDSCs by their slow adherence to collagen 
coated flasks.  Those cells that adhere after two hours in media culture conditions constitute pre-
plate 1 (PP1) and non-adherent cells are transferred to a new flask.   Successive 24hr preplate 
cycles segregate pre-plate populations PP2 through PP6.  After 10-12 passages of the PP6 
population, a long-term proliferating population of MDSCs is established.  MDSCs, even when 
expanded from clonal populations express variable surface markers and cytoplasmic markers of 
stem cell and myogenic lineage such as CD34, Flk-1, Sca-1, MyoD, and desmin80,81.   However, 
MDSCs have been shown to differentiate into musculoskeletal tissues such as bone, cartilage, 
and skeletal muscle, in addition to endothelial, neural and hematopoietic tissues42,77,78,80,82-84.  
Perhaps more important than MDSC multipotency, however is the increased rate of survival and 
subsequent engraftment in skeletal muscle when compared to myoblasts. 
Although the MDSCs isolated by our laboratory were derived from skeletal muscle, 
many sources may be considered, given previous studies in which pluripotent bone marrow stem 
cells63,65,85-89, blood vessel progenitors90-94, neural stem cells95-97, and cells from other connective 
tissues, including adipose tissue98,99 and dermis100, have all shown the capacity to differentiate 
into myogenic cells.  Many of these cell types appear to be able to undergo myogenic lineage in 
vitro but their participation in the regeneration of skeletal muscle in vivo after injury or disease 
has been found to be extremely limited (especially the hematopoietic, bone marrow and other 
circulating precursors)101,102. Among all of these different cell types, it appears that blood vessel 
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progenitors (including mesangioblasts) share a number of features with the MDSCs identified by 
our group.  In particular, they share cell-type marker profiles and have high myogenic potentials 
in vitro and in vivo; similarities that suggest a possible relationship between these types of 
cells45. 
1.4 CHALLENGES IN TRANSLATION OF MYOGENIC CELL 
TRANSPLANTATION 
Early clinical trials of myoblast transfer therapy therapies faced difficult challenges, including 
immune rejection, poor cell spreading (less than 200µm from injection site), as well as rapid 
death on injection45.  Many studies have generated novel ideas for ameliorating these obstacles 
and increasing efficiency of engraftment, however they have yet to translate into a clinically 
viable solution for DMD treatment. 
The first major breakthrough in developing this therapy came with the validation of the 
mdx mouse model of DMD, which ushered in studies of cell transplantation and evidence of 
engraftment of dystrophin positive fibers in this model22,103.  What followed were human clinical 
trials that demonstrated limited engraftment of dystrophin positive myofibers10-12,23,28,30,104,105. In 
Human clinical trials, myoblast transfer therapy proved to be of limited therapeutic value due to 
low efficiency of engraftment, delivery of dystrophin to the deficient muscle, and poor rates of 
improvement of muscle function.  Mendell et al. attained a biceps muscle engraftment rate of 
~10% using cyclosporine immunosuppression, yet muscle function tests were disappointing28.  
Ironically it was found that cyclosporine can induce apoptosis in differentiating myoblasts, 
despite the survival benefit of immunosuppression106,107.  Further studies confirmed that the poor 
  9 
engraftment efficiency arose due to immune rejection18,31,108, limited cell spreading109, and a 
phenomenon of rapid cell death within 48hrs of injection9,17,18,47,110,111.   
1.4.1 Acute immunogenicity of myogenic cell transplantation 
Upon injection into the host skeletal muscle, there are a number of simultaneous immune related 
responses that endanger the survival of the donor cells. Insertion of the needle and injection of 
fluid in the muscle will induce tearing of multiple groups of myofibers and vascular structures 
which will initiate an immune reaction associated with myofiber damage and necrosis as well as 
a clotting cascade, both of which will stimulate a state of inflammation.  It is possible that this 
reaction is similar phenomenon of instant blood-mediated inflammatory reaction (IBMIR) 
observed in pancreatic islet cell transplantation112.  IBMIR is essentially a thrombotic and 
inflammatory reaction observed in islets cells infused into the portal vein, which is induced by 
tissue factor expression of the islet cells113.  Rapid leukocyte infiltration, especially that of 
neutrophils, is thought to incur a rapid loss of cell viability within the first minutes and hours of 
transplantation113.   In the case of myogenic cell intramuscular injection, inflammation rapidly 
alters the environment of the injection site in terms of the redox state, the nature and 
concentration of pro-inflammatory cytokines, the presence and activity of inflammatory cells, 
and consequently the phenotypic expression of host and donor cells.  This complex interplay of 
host and donor cells is briefly reviewed below. 
The hallmarks of inflammation are increased vascular permeability, activation of 
inflammatory cells, and change in the intra- and extracellular redox state114.  Rupturing the 
sarcolemmal membrane of the myofiber will allow Ca++ influx, lysosomal enzyme efflux and 
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expose neighboring cells including macrophages to other cellular products of necrosis which 
induce inflammation within seconds or minutes44. 
Neutrophil and macrophage infiltration propagates inflammation by releasing cytotoxic 
chemicals and pro-inflammatory cytokines (e.g. TNF-α, IL-1, and IL-6).  Degranulation of 
neutrophils releases reactive oxygen species, such as superoxide (O2.) a highly reactive ROS that 
can be converted to H2O2 by superoxide dismutase, which can interact with iron and by a Fenton 
reaction can be converted to the hydroxyl radical (OH.), a far stronger oxidant115.  This not only 
causes cellular damage via protein oxidation and lipid peroxidation but oxidizes intracellular 
non-enzymatic anti-oxidant molecules such as reduced glutathione (GSH) and alters the 
intracellular redox balance toward a pro-apoptotic state57.  There are many putative mechanisms 
by which muscle cells sense changes in their intra- and extra-cellular environment116,117, however 
one common signaling pathway upregulated by inflammation is NF-κB nuclear 
translocation118,119.  Upregulation of NF-κB has a number of potential effects including 
upregulation of genes associated with anti-oxidant defenses, quiescence, and apoptosis120,121.  Its 
activity in muscle cells remains poorly understood, however recent studies of p65 (a class I 
member of the NF-κB family) knockout (KO) muscle derived stem cells suggest that p65 KO 
cells have increased oxidative stress tolerance in vitro and yield increased rates of engraftment 
when injected into the mdx mouse gastrocnemius muscle (A. Liu et al., unpublished 
observation).   
Studies of various muscle injuries, including eccentric loading and ischemia/reperfusion 
injuries, have shown that neutrophil infiltration occurs within an hour of injury and can remain 
for up to five days44.  The rapid sequence of events that precedes neutrophil invasion is not fully 
elucidated, however there is evidence that the muscle itself can promote inflammatory cell 
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invasion.  Human satellite cells have been shown to release factors that promote 
macrophage/monocyte endothelial transmigration in vitro44,122.  Neutrophil invasion is important 
to healing insofar as they release proteases that help clear muscle debris created by injury, 
however the cytotoxic species such as superoxide anion released on neutrophil degranulation 
also cause damage to bystander cells promoting further inflammation. 
It is clear that macrophages also rapidly invade the injured muscle, but they have a far 
more complex role.  They participate in cell lysis using a nitric oxide (NO) dependent 
mechanism and phagocytose cell debris.  They then take a mediating role in the inflammatory 
process by promoting further immune cell infiltration (e.g. neutrophils, NK cells), however once 
necrotic cell debris has been cleared they undergo a phenotypic change that allows them to 
participate in the healing and regeneration phase of injury36,48,49.  This change in role is 
associated with its conversion from an inflammatory phenotype (M1) to that of a healing 
phenotype (M2)114. In fact, macrophage depletion has been shown to greatly inhibit muscle 
healing36. 
Damage of vascular barriers that is induced on injection of myoblasts is likely to 
stimulate activity of the clotting system, whose activity is pro-inflammatory through the protease 
activity of thrombin (factor IIa)114.  Thrombin binds protease activated receptors (PARs), which 
are G-protein-coupled receptors expressed on platelets, endothelial and smooth muscle cells.  
Binding induces several pro-inflammatory events including production of chemokines and 
expression of leukocyte adhesion molecules necessary for leukocyte binding and diapedesis114.  
However, to my knowledge experiments exploring the utility of interrupting the clotting cascade 
on myoblast survival have not been pursued. 
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The timing of cell death immediately following transplantation suggests loss by the 
innate and non-specific humoral immune system.  One basic component of the non-specific 
humoral immune system is complement activity, in which 20 complement proteins coordinate to 
form a membrane perforating membrane attack complex (MAC)123 as well as to activate B-
cells124.  However, several of the complement proteins (C3a, C5a, and C4a) also act to stimulate 
resident mast cells to release histamine, which causes vasodilatation and increases vascular 
permeability.  C5a is a powerful chemotactic agent for neutrophils, monocytes, eosinophils, and 
basophils and can also stimulate phospholipase activity, which initiates arachodonic acid 
production. However, complement depletion has been shown to only marginally improve 
transplanted myoblast survival125. 
Subsequent detection of foreign cells by macrophages generates numerous chemotactic 
signals that trigger infiltration of natural killer (NK) cells.  NK cells are lymphocytes that 
recognize and kill cells that do not express a “self’ major histocompatibility complex class I 
(MHC-I) surface protein126.  They target exogenous cells by secreting membrane perforating 
enzymes such as perforin and granzyme, which may induce apoptosis or pro-inflammatory 
necrosis.  NK cells often coordinate with CD8+ or cytotoxic T-cells to kill foreign cells which 
has also been a focus of myogenic cell transplantation optimization108, although these studies are 
inconclusive and offer conflicting conclusions on the importance and temporal profile of their 
infiltration51,127,128. 
1.4.2 Limited migration of transplanted myogenic cells 
Poor myoblast migration following intramuscular injection is likely a consequence of the 
connective tissue barriers that exist between muscle fibers.  Skeletal muscle is surrounded by 
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fibrous connective tissue at multiple scales.  At the finest scale, myofibers are made within 
endomysial tissue, groups of which are organized into fascicles by perimysium.  At the largest 
scale, epimysium and a thick muscle fascia encases the entire muscle body.  Each scale of 
connective tissue generates an increasing barrier to myoblast migration.  Several studies have 
suggested that myoblast migration may be mediated by the production of metalloproteinases, 
particularly MMP-1 and MMP-2129.  Production of these metalloproteinases could be stimulated 
by viral transfection or in the case of MMP-9, by simple treatment with basic fibroblast growth 
factor (bFGF) or tumor necrosis factor (TNF-α).  Furthermore soluble fibronectin yielded 
increases in MMP-1 activity.  Interestingly, n-acetylcysteine, which may increase the anti-
oxidant capacity of the myoblast, was shown to decrease MMP activity (particularly MMP-2 and 
MMP-9) and connective tissue transmigration in vitro129,130.  Poor spreading can also be 
overcome by increasing the number and density of injection sites.  In one monkey trial 
engraftment was enhanced by injecting 30 million cells per square millimeter109.  Recent clinical 
trials in Canada of a similar “high density” injection technique (~100 injections per square cm of 
muscle surface) with tacrolimus immunosuppression demonstrated the feasibility of long-term 
dystrophin expression (up to 18 months)131,132.  While the prospect of receiving “high density” 
injections to all dystrophic muscles would not seem clinically feasible as a standard treatment, it 
was well tolerated by the eleven patients enrolled in these trials, which should be considered in 
light of the severity and progressive nature of DMD. 
Intravascular delivery of myogenic cells may offer a more favorable distribution of 
dystrophin expressing fibers especially in muscles such as the diaphragm.  Capillary networks 
reach all myofibers of a given muscle and cells could be selected to home to areas of 
inflammation.  Several studies have demonstrated the feasibility of this delivery route67,68.  The 
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promise of this technique relies on the interaction of VLA-4 in CD133+ stem cells with 
endothelial vascular cell adhesion molecule (VCAM-1) in areas of muscle inflammation45. 
1.4.3 Immune rejection of transplanted myogenic cells 
Immune suppression is typically required to induce successful engraftment of allogenic 
myoblasts.  Tacrolimus (or FK506) has often been used to control inflammation and graft 
rejection because it, like cyclosporine, interacts with calcineurin to inhibit both T-lymphocyte 
signal transduction and IL-2 transcription133.  Chronic administration following transplantation 
appears to be necessary as when it is withdrawn the transplanted myoblasts die in short 
order134,135.  The nephrotoxic and carcinogenic side effects of chronic tacrolimus limits the utility 
of this approach. Immune tolerance can be induced either by non-myeloablative irradiation 
treatments with anti-CD45RB to anti-CD154136 or cyclophosphamide and busulfan137 or central 
tolerance using whole body irradiation and allogenic bone marrow transplant136.  However, this 
central tolerance does not seem to include all muscle neoantigens following myoblast 
engraftment138. It should be noted that some myogenic cells under study have demonstrated 
immune privilege such as muscle derived stem cells, thus long term allogenic cell engraftment 
without immune suppression may be possible42. 
1.4.4 Reactive oxygen species and antioxidant capacity of MDSCs 
Our lab has focused considerable effort on isolating and characterizing skeletal muscle derived 
multipotent cells, called muscle derived stem cells79.  This population of cells have been shown 
to be heterogeneous in terms of cell surface markers (e.g. CD56, CD34, and Sca-1) has a 
  15 
tendency to change during in vitro expansion42.  Rather they are isolated by a modified preplate 
technique in which cells that are slow to adhere to a collagen coated flask have been shown to 
display stem cell markers and behavior79.  We ascertained that MDSCs were not only 
multipotent but their regenerative capacity in both skeletal and cardiac muscle consistently 
exceeded that of early preplate myoblasts.  In a sense the failures of MTT paved the way for the 
discovery of MDSCs as the putative subpopulation of cells that survive the transplantation15,139. 
Reactive oxygen species in addition to reactive nitrogen species (RNS) have received a 
great deal of attention recently given their pathologic implications in aging, cancer, and 
inflammatory diseases as well as their important signaling functions120,140-142.  Clearly the redox 
environment of the intramuscular injection site is altered by the action of neutrophils and 
macrophages as they generate numerous cytolytic ROS and RNS species.  Neutrophils rely on 
NADPH oxidase 2 (NOX2) to transfer electrons to oxygen to create the superoxide radical that is 
itself quite toxic but can be converted to far more reactive hypochlorous and hypobromous acids 
by the sequential action of superoxide dismutase (SOD) and myeloperoxidase143,144.  These 
oxidizing species are extremely efficient in oxidizing thiols and other biomolecules which can 
shift the redox balance intra- and extracellularly.  Similarly, macrophages induce cell-lysis 
though production of nitric oxide via nitric oxide synthase (NOS2 or iNOS), rather than 
superoxide production145. 
One intriguing characteristic of MDSCs that appears to correlate quite well with its 
regeneration capacity is its resistance to oxidative and inflammatory stress.  We have found that 
these cells produce constitutively higher levels of GSH and SOD than their more differentiated 
myoblast counterparts52.  They maintain their myogenic differentiation and proliferation capacity 
as well as their ability to resist apoptosis in the presence of oxidative (H2O2) and inflammatory 
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challenge (TNF-α)43,52.  When GSH levels are depleted by diethyl maleate their regenerative 
capacity in both cardiac and skeletal muscle is reduced52.  On the other hand when the GSH 
levels of MDSCs were increased by treatment with n-acetylcysteine, their regenerative capacity 
in skeletal and cardiac muscle was increased130.    Recent studies have shown that the cells that 
survive and engraft also have increased oxidative and inflammatory stress tolerance in vitro52. 
In fact, stress tolerance may be an essential attribute of stemness.  This has been found in 
multiple lineages including neural stem cells146, hematopoietic stem cells147, endothelial 
progenitor cells148,149, cancer stem cells150-152, and other circulating progenitors153.  One may 
speculate that this is a consequence of a logical evolutionary drive to protect these rare and 
multipotent cells from senescence and dysfunction through oxidative damage.  It also appears to 
be a signaling mechanism to preserve the progenitor phenotype154,155.  A major focus of this 
dissertation is a finding that sorting muscle derived cells on aldehyde dehydrogenase (ALDH) 
activity yields a subpopulation of ALDHhi cells with not only increased stress tolerance but also 
increased rates of engraftment when injected in the mdx mouse.  From the perspective of 
regenerative medicine this anti-oxidant capacity offers another critical benefit of stem cells for 
cell therapy and may prove to be a primary determinant of the efficacy of stem cell therapy52.   
ALDH plays an essential role in regulating retinoic acid production, which has been shown to 
mediate differentiation in a number of tissue specific stem cell populations156-159.  However, why 
ALDH production appears to be upregulated in a number of tissue specific stem cells is not 
entirely clear, however it’s role in stem cell maintenance is likely to stimulate further study given 
its increasingly important role in isolating somatic stem cells. 
The cell’s normal anti-oxidant defenses include enzymatic and non-enzymatic scavengers 
such as SOD, GSH, catalase, glutathione peroxidase, thioredoxin, and a peroxiredoxin family of 
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proteins160.  These molecules are responsible not only for protecting the cell from oxidative 
damage but they are also responsible for maintaining a precise intracellular balance of redox 
potential, given the important signaling role of reactive oxygen species.  Augmenting these 
normal anti-oxidant defenses may improve transplanted cell survival post-transplantation.  
Exogenous and synthetic SOD has been used to preserve function in isolating islet cell grafts and 
may prove useful for myogenic cell engraftment as well161,162.  Thiol based anti-oxidants are also 
of interest in improving engraftment such as n-acetylcysteine163-167.   
1.4.4.1 Calcium dysregulation and the mitochondria 
Following membrane damage through oxidative stress and other mechanisms, excess cytosolic 
calcium concentrations can activate Ca++ dependent proteases such as the calpains168.   However, 
Ca++ dysregulation can trigger other pro-apoptotic pathways by interactions with muscle 
mitochondria169.  Ca++ plays a physiologic role in regulating mitochondrial dehydrogenases by 
increasing NADH levels to fuel the respiratory chain.  However, if the mitochondrial matrix 
becomes overloaded with Ca++, it can trigger the opening of the mitochondrial permeability 
transition pore (mPTP) which destroys the proton motive force (pmf), including pH and 
mitochondrial ionic potential.  This pore opening is further potentiated by oxidative stress170-172. 
With the loss of pmf, mitochondrial ATPases are driven to reverse their ATP forming 
reactions such that they consume ATP to pump protons out of the mitochondria.  ATP depletion 
leads to loss of ion homeostasis throughout the cell and ultimately necrotic cell death169.  A 
further deleterious consequence of mPTP opening is mitochondrial swelling driven by colloidal 
osmotic pressure from matrix proteins.  This can perforate the outer mitochondrial membrane 
and release pro-apoptotic proteins such as cytochrome C169.  However there are drugs that have 
been shown to inhibit mPTP opening through interactions with the matrix protein cyclophilin-D, 
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such as cyclosporin-A173 and sanglifehrin-A174, which may have some value in improving 
engraftment efficiency175,176. 
1.4.5 Aldehyde dehydrogenase: A marker for early progenitor status 
Aldehyde dehydrogenase represents a family of enzymes that are responsible for the conversion 
of aliphatic and aromatic aldehydes to their corresponding carboxylic acids.    It is also 
considered a detoxifying enzyme by eliminating reactive exogenous and endogenous 
aldehydes177.   It has a vital role in embryological development by its conversion of 
retinaldehyde to retinoic acid, which mediates numerous developmental processes including 
somite migration, limb patterning, and tissue differentiation178.  Retinoic acid induces 
differentiation by binding RARs (retinoic acid receptors), RXR (retinoid X receptor) associated 
transcription factors, and nuclear (RAREs) (retinoic acid response elements).  Initial interest in 
the ALDH as a marker of hematopoietic stem cells (HSCs) began with an observation that HSCs 
with elevated ALDH are spared from cyclophosphamide ablation and subsequent elucidation of 
the role of ALDH in detoxifying this alkylating agent179. 
Elevated expression of ALDH has been shown to be a marker of early progenitor status 
in hematopeitic180,181, mesenchymal182, endothelial183, neural184,185, and recently skeletal 
muscle186 populations.  ALDH expression is associated with retinoic acid metabolism, a mediator 
of stem cell maintenance and differentiation, and confers oxazaphosphorine chemotherapy 
resistance in metastasis competent cancer stem cells151,187,188.   Using elevated ALDH activity as 
a marker to isolate somatic stem cells has particular utility in light of the commercial availability 
of a boron-dipyrromethene (BODIPY) labeled amino acetaldehyde (BAAA) that fluoresces when 
oxidized by the cytosolic isoform of ALDH (ALDH1A1).  BAAA diffuses freely into the 
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cytoplasm and is converted to BIODIPY-aminoacetate by ALDH189.  Cells with elevated ALDH 
activity become fluorescent when exposed to boron-dipyrromethene (BODIPY) labeled amino 
acetaldehyde (BAAA) and can be isolated using fluorescence activated cell sorting (FACS).   
Furthermore, given the role of ALDH in embryological development and organism-wide tissue 
differentiation processes, its use as a marker to isolate early progenitor cells has sparked a surge 
of research activity in the somatic stem cell and cancer stem cell fields. 
Many of the early progenitors, including somatic and carcinoma stem cells, that may be 
isolated by elevated ALDH activity have also be shown to have increased anti-oxidant capacity. 
In hematopoietic stem cells which can be isolated by multiple markers such as CD133, CD34, 
and ALDH, increased stress oxidative resistance is conferred by increased expression of the 
FoxO (Forkhead O) transcription factors190.   The FoxO family of transcription factors play 
mediating roles in cell cycle arrest, oxidative stress resistance and apoptosis191.   They are 
downstream targets of the PI3K-AKT pathway and regulators of the oxidative stress response, 
which includes induction of MnSOD, catalase, and GADD45192-194.  Similar properties of 
increased expression of free radical scavenging systems and decreased levels of reactive oxygen 
species is observed in epithelial breast cancer stem cells which confers increased resistance to 
ionizing radiation therapy195.  Similar properties were found in non-tumorigenic mammary 
epithelial stem cells.  Breast cancer stem cells with increased malignancy and metastasis 
competence have been found to have increased ALDH activity150.  In umbilical cord blood cells 
which may isolated ALDH activity have also been shown to give rise to endothelial progenitors 
with elevated MnSOD levels that significantly increases their oxidative stress resistance and 
therefore utility in treating ischemic tissue148,196. 
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In adult tissues, the role catalytic and metabolic role of the ALDH family of enzymes is 
in an active area of research.  Its enzymatic activity in the conversion of aldehydes to their 
corresponding carboxylic acids proceeds by the following reaction: 
 
Figure 1.  General reaction of aldehyde dehydrogenase197 
It is the cytosolic form of ALDH, ALDH1A1, which has been the focus of many studies aimed at 
isolating somatic and carcinoma stem cells.  Although it’s activity in oxazaphosphorine 
chemotherapy resistance is well documented, it is not at all clear whether it directly participates 
in the oxidative stress resistance of these cells198.  While our studies suggest that ALDH may be 
simply a marker for early progenitor status, it is also possible that it replenishes NADPH levels 
by conversion of endogenous aldehydes, which would provide a necessary substrate for reduced 
glutathione recycling (GSSG  2 GSH) via the multiple NADPH dependent enzymes such as 
glutathione reductase199. 
Vauchez et al. recently identified an ALDH+ myogenic progenitor population in skeletal 
muscle, which occupies an endomysial niche similar to that of the satellite cell186.  The CD34- 
subpopulation of these cells were found to be myogenic both in vitro and in vivo.  Another 
important result from this paper was the robust engraftment of these ALDH+CD34- cells in the 
skeletal muscle of SCID mice.  The co-authors estimated that the engrafted cell population at 4 
weeks post-transplantation was roughly 2-5 times the number of cells that were injected, as 
estimated the number of donor nuclei counted in 8-10 serial cryosections.  Perhaps more 
importantly however was that the transplanted cells not only fused with existing myofibers but 
many of some of these cells took up residence in an endomysial niche.  This suggests that these 
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cells may not only be used to induce immediate skeletal muscle repair but also to replenish the 
satellite cell reservoir.   Although these results were quite similar to our study on ALDHhi muscle 
derived cells, our study focuses on the potential of these cells for myogenic therapy in mitigating 
the phenomenon of rapid cell death, particularly on the cells’ ability to withstand oxidative and 
inflammatory stress. 
1.5 SPECIFIC AIMS OF DISSERTATION 
Myogenic cell therapies have been limited by rapid and precipitous cell death within days of 
transplantation41,200,201.  Several mechanisms for this loss have been proposed including 
inflammatory and oxidative stress at the injection site18,41,127,202, hypoxia/ischemia203, and anoikis 
(apoptosis induced by loss of extracellular matrix (ECM) or adjacent cell contact)204,205.  In fact 
most cell therapies suffer from poor post-transplantation survival206-209.  Increased engraftment is 
observed following inhibition of LFA-118 and IL-141, implicating inflammation and the innate 
immune response.  However direct interference with immune cell signaling and recruitment is 
problematic because the actions of pro-inflammatory cells such as the macrophage are essential 
for subsequent muscle healing36,48,49,114.  Instead enhancing the rate of survival of these post-
transplantation events by scavenging the numerous cytolytic reactive oxygen species produced 
by neutrophils and macrophages may improve engraftment efficiency without hindering 
subsequent regeneration210.  In this study, we specifically address transplanted cell survival as it 
relates to inflammation and oxidative stress.  Recently, we observed a correlation of increased 
inflammatory and oxidative stress resistance in vitro in myogenic cells with increased 
regeneration capacity in vivo52,74.  When the antioxidant defenses of the transplanted cells were 
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enhanced or depleted we observed a corresponding increase or decrease in regeneration of the 
treated tissue52,130.  These observations led us to hypothesize that myogenic cells with enhanced 
capacity for stress resistance, a putative characteristic of stem and early progenitor cells, will 
induce increased skeletal muscle regeneration compared to myogenic cells with less stress 
resistance capacity.  
To test this hypothesis, I proposed three specific aims.  The first sought to differentiate 
the effects of myogenic capacity from stress resistance on muscle regeneration capacity in vivo.  
A sub-aim of this aim was to seek to enhance the regenerative capacity of myogenic cells using a 
mitochondrial targeted ROS scavenger, XJB-5-131.  The second aim sought to segregate murine 
myoblasts and MDSCs in ALDHhi and ALDHlo sub-populations to determine whether the anti-
oxidant and regenerative capacity of ALDHhi cells are enhanced compared to ALDHlo and 
unsorted preplate populations. The third aim was designed to characterize a human muscle 
derived cell population isolated by their enhanced ALDH activity in terms of stress resistance in 
vitro and regeneration capacity in vivo. 
1.5.1 Specific Aim 1: To elucidate the role of survival in myogenic differentiation capacity 
in vitro and in muscle regeneration capacity in vivo 
Hypothesis: While myogenic capacity is a prerequisite for effective cell therapy, enhanced cell 
survival in oxidative and inflammatory stress is the determinant of regeneration capacity.  As 
such, pretreatment of myogenic cells with an ROS scavenger, XJB-5-131, will improve post-
transplantation survival and muscle regeneration capacity.  We have demonstrated that MDSCs 
are more resistant to oxidative and inflammatory stress relative to more differentiated muscle 
cells, including myoblasts, which we believe contributes to the enhanced capacity of MDSCs to 
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regenerate injured musculoskeletal tissues.  However, the reduced ability of early preplate (EP) 
myoblasts to survive and differentiate in vitro and in vivo may be due to their increased 
sensitivity to stress.  We will measure the survival, proliferation and differentiation potential of 
early preplate cells after exposure to inflammatory cytokines (TNF-α) and hydrogen peroxide 
(H2O2) in differentiation media.  These experiments are designed to reveal if the decrease 
capacity of myoblasts to differentiate is due to decreased resistance to stress.  While improved 
anti-oxidant defense appears to improve post-transplantation survival in MDSCs, we will 
determine if the myoblast regeneration capacity can be improved simply by improving its anti-
oxidant capacity.  XJB-5-131 is a membrane permeable, mitochondrial targeted ROS scavenger 
with low toxicity and will be used to increase the anti-oxidant levels of both myoblasts and 
MDSCs. 
1.5.2 Specific Aim 2: To determine the muscle regeneration capacity of a sub-population 
of murine preplate cells with elevated stress resistance 
Hypothesis:  While the preplate technique has been shown to isolate murine myoblasts and 
muscle derived stem cells, the muscle regeneration capacity of these cells may be enhanced by 
isolating sub-fractions with elevated ALDH activity, a marker of early progenitor status. ALDH 
is a modulator of the embryonic morphogen retinoic acid and is highly expressed in several 
tissue specific progenitors and adult stem cells.  ALDHhi and ALDHlo sub-populations of muscle 
derived cells were isolated in order to compare their proliferation, differentiation, and 
regeneration capacities in conditions of inflammatory and oxidative stress. 
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1.5.3 Specific Aim 3: To determine the stress resistance and myogenic capacity of 
cultured human muscle derived cells with elevated aldehyde dehydrogenase (ALDH) 
activity 
Hypothesis: Human muscle derived cells with elevated ALDH activity (ALDHhi) will demonstrate 
enhanced stress resistance and regeneration capacity when compared to ALDHlo and unsorted 
muscle derived cells.  Vauchez et al. recently detected the presence of endomysial cells with 
elevated ALDH activity, which were isolated and shown to undergo myogenic differentiation in 
vitro and in vivo.  We will isolate ALDHhi subpopulation of cultured human muscle derived cells 
(hMDCs) and determine their stress resistance and differentiation capacity in vitro and in vivo. 
1.5.4 Tissue specimen acquisition and animal use 
1.5.4.1 Human Subjects   
Tissue from RIA procedures were obtained through the honest broker system and University of 
Pittsburgh IRB #PRO0305079.  Skeletal muscle was obtained from surgical tissue specimens 
from orthopedic procedures that would otherwise be discarded.  The excised tissue was placed in 
phosphate buffered saline solution and transferred to the host broker who de-identified and 
transported it to the Bridgeside Point II Research Building, where it was given to investigators at 
the Stem Cell Research Center.   
1.5.4.2 Vertebrate Animals   
The use of animals required for these studies was approved by the IACUC of University of 
Pittsburgh prior to the experiments.  All animals were cared for by the Division of Laboratory 
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Animal Resources at the University of Pittsburgh Biomedical Science Tower, S 1040.  The 
University of Pittsburgh adheres to the NIH Guide for Care and Use of Laboratory Animals.  
Institutional guidelines for the use and care of animals in research are assured by the Animal 
Welfare Assurances of the University of Pittsburgh.  The investigators adhere to the instructions 
described in the Guide for the Care and Use of Laboratory Animals (NIH Publications 85-23) as 
promulgated by the Committee of Care and Use of Laboratory Animals of the Institute of 
Laboratory Sciences, the National Academy of Sciences, and the National Research Council.  All 
of the animals were euthanized by way of compressed CO2 (70%) gas until unconscious than 
CO2 were increased to 100% until death, consistent with the recommendations of the Panel on 
Euthanasia of the American Veterinary Medical Association. 
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2.0  SPECIFIC AIM 1:  ROLE OF CELL SURVIVAL IN MYOGENIC CAPACITY 
2.1 BACKGROUND 
2.1.1 Myogenic cell transplantation is limited by poor cell survival 
The rationale for myogenic cell transplantation is to augment or recapitulate the normal 
mechanism of skeletal muscle regeneration by transplanting myogenic progenitors into the 
injured muscle.  Cells with myogenic potential have been isolated from skeletal muscle42,65,66, 
bone marrow62-64, circulating blood67,68, and blood vessels69-71.  Myogenic progenitors isolated 
from skeletal muscle appear to be physically associated or share a common lineage with blood 
vessels72-76.  While their contribution to normal muscle maintenance and regeneration appears to 
be quite small211, when expanded exogenously and transplanted they have been shown to 
promote regeneration either by regeneration of muscle fibers or paracrine mediated repair 
processes. However, limitations of myogenic cell transplantation remain including: rapid cell 
death, limited cell migration, and immune rejection9-32. 
Myogenic cell transplantation therapies are limited primarily by high mortality rate (up to 
99%) of the injected cells within the first few days of transplantation9,16,47,200, which is of the 
same timeframe as rapid activation and infiltration of polymorphonuclear (PMN) cells.  The 
degranulation of PMNs and other inflammatory leukocytes creates a local environment of 
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inflammatory and oxidative stress that is deleterious to transplanted cell survival18,41,47,162,207,212-
217.  Qu et al. observed increased concentrations of pro-inflammatory cytokines such as IL-1α, 
IL-1β, and TNF-α at the site of myoblast injection41.  Ischemia and hypoxia of the implanted 
cells is another likely source of cell death that has been shown to induce intracellular oxidative 
stress203, 218. 
The process of inflammation yields a condition of oxidative stress in affected tissue114. 
This occurs by both the release of oxidizing species by inflammatory cells such as neutrophils 
and macrophages and by receptor mediated cytokine signaling that modifies the intracellular 
redox environment.  Following a muscle injury an increased accumulation of neutrophils may be 
observed at the injury site within 1hr and remain for up to 5d44.  The role of neutrophils appears 
to be primarily cytotoxic and cytolytic to prepare the injured site for debris phagocytosis.  This is 
immediately followed by the accumulation of macrophages in their type I, or pro-inflammatory 
state, which by their secretion of numerous cytokines, growth factors, and oxidizing species, 
promotes satellite cell activation219.  During the oxidative burst, neutrophils generate ROSs by 
reducing O2 to superoxide anion via NADPH oxidase 2 (NOX2), which is converted to hydrogen 
peroxide by SOD and may be subsequently converted by myeloperoxidase to far more reactive 
hypochlorous and hypobromous acids143,144.  Similarly, macrophages may induce cell-lysis 
though production of nitric oxide via nitric oxide synthase (NOS2 or iNOS)115,145.  These species 
may cause oxidative damage via protein oxidation and lipid peroxidation thus modifying protein 
and lipid structural, chemical, or signaling functions57,116-119. 
The role of hydrogen peroxide as an effector, mediator, and second messenger in the 
process of inflammation is the subject of much ongoing research.  It not only acts as a cytotoxic 
reactive oxidizing species, but can also potentiate or amplify the TNF-α activation of NF-kB220.  
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It also is generated intracellularly by mitochondria following TNF-α binding to TNF-R1221,222.  
In vivo measurements of hydrogen peroxide during inflammation (5-15µM)223 are lower than 
that needed to disturb proliferation and differentiation in vitro (25-500µM)52,224.  However, it 
should be kept in mind that cells in vivo are exposed to H2O2 in concert with other oxidizing 
species and pro-inflammatory cytokines.  Furthermore the serum rich media in which hydrogen 
peroxide is diluted will reduce much of the H2O2 via serum protein and lipid peroxidation.  
Therefore elevated concentrations of H2O2 were required to measurably perturb cell behavior 
such as proliferation and myogenic differentiation. 
2.1.2 Increased stress resistance is associated with enhanced regeneration capacity 
Oxidizing species such as ROS are linked not only to transplanted cell death but also altered 
signaling through MAPK, NF-kB, and Forkhead box O (FOXO) transcription factors, which can 
affect phenotype and cell activity such as proliferation, differentiation, and apoptosis118,155,225,226.  
The cell maintains a complex system of enzymatic and non-enzymatic mechanisms in order to 
regulate this redox state, including GSH, glutathione peroxidase (GPX), glutathione reductase 
(GR), catalase, SOD, and others which are depicted in Figure 2120.  The primary scavenger of 
oxidants in the cell is GSH, a cysteine containing tripeptide whose thiol group may donate its 
electron and form a disulfide with another GSH molecule (GSSG).  Intracellular GSH 
concentrations are in the millimolar range, orders of magnitude greater than any other cellular 
anti-oxidant.  In fact, a simple measure of the cell’s redox state is the ratio of GSH to GSSG 
concentration. 
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Figure 2.  Schematic of major intracellular antioxidants 
 
The maintenance of stem cell reserve is critical to repair damaged tissue or replace 
senescent cells over the course of our lifetime, especially in those tissues such as skeletal muscle 
that are exposed to frequent cycles of stress and damage requiring nearly constant repair and 
regeneration.  It follows that these tissue specific stem cells should have a mechanism to protect 
themselves from cycles of inflammatory and oxidative stress.  Oxidative stress is defined as the 
injurious effects such as lipid, protein, or DNA oxidation of oxidizing molecules that exceeds the 
cell’s ability to neutralize or eliminate them.  Whereas inflammatory stress is the exposure to or 
generation of pro-inflammatory cytokines that may activate the various signaling pathways of 
NF-kB as well alter the redox status of the cell.  Protection from these stresses may be 
extracellular, in the form an isolated or immune privileged niche or intracellular in the form of 
enhanced mechanisms to reduce or eliminate intracellular oxidizing species.  Some studies have 
also shown increased expression of anti-oxidant enzymes in stem and progenitor cells154,227,228.  
In our studies of the MDSCs, we have found increased levels of SOD and GSH over that of the 
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myoblast, conferring a constitutive readiness to mitigate oxidative stress.  This, we believe, is a 
critical aspect of increased regeneration capacity in cardiac and skeletal muscle of MDSCs52. 
Urish et al. observed that MDSCs have a survival and differentiation advantage over 
myoblasts when exposed to oxidative (H2O2) and inflammatory stress (TNF-α) in vitro52.  In the 
same paper, co-authors observed that increased stress tolerance correlated with increased 
intracellular concentrations of the anti-oxidants GSH and SOD and with decreased levels of 
intracellular reactive oxygen species.  To assess the impact of this increased antioxidant capacity 
on the in vivo regeneration capacity, GSH levels of the MDSC were depleted to that of 
myoblasts using diethyl maleate (DEM) prior to skeletal muscle transplantation229.  Indeed, the 
regeneration index (RI, defined as the maximum number of dystrophin positive myofibers per 
100,000 of injected cells in a single cryosection) of the DEM treated MDSCs in skeletal muscle 
was significantly less than untreated MDSCs but was not significantly greater than the myoblast 
group52.  In recent work by Drowley et al., MDSCs treated with n-acetylcysteine, a GSH 
precursor substrate and anti-oxidant, prior to myocardial transplantation induced greater 
functional recovery following coronary infarction than untreated MDSCs130.  Although this 
increased functional recovery is thought to be due to paracrine action and promotion of 
angiogenesis rather than by cardiomyocyte differentiation of MDSCs, the improved functional 
outcome suggests improved survival and subsequent action of the transplanted MDSCs.  
2.1.3 Targeting mitochondrial reactive oxygen species to improve myogenic cells survival 
While inflammatory events yield extracellular ROS, oxidative damage of the transplanted cells 
as well as cytokine mediated signaling also alter the intracellular redox status.  During exposure 
to oxidative stress and hypoxia, reactive oxygen species are generated within the cell, primarily 
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by mitochondria, which can affect pathways of differentiation, proliferation, quiescence, 
senescence, and apoptosis230.  The mitochondrion is particularly suited to generate ROS as it is 
constitutively shuttling electrons from molecular oxygen through the complexes of the electron 
transport chain.  During this process, electrons may leak from complex III and complex I to 
produce superoxide radicals, which may peroxidize mitochondrial phospholipids such as 
cardiolipin231,232.  This may in turn release cytochrome C and allow mitochondrial transition 
pores to form, both of which may induce apoptosis233-235. 
XJB-5-131 (XJB) is a mitochondrial targeted anti-oxidant with two moieties: a ROS 
scavenging payload and a mitochondrial targeting fragment of the antibiotic gramicidin S236,237.  
The ROS scavenging is performed by a stable nitroxide radical, 4-hydroxy-2,2,6,6-tetramethyl 
piperidine-1-oxyl (TEMPOL).  Upon accepting an electron the nitroxide is converted to a 
hydroxylamine, which can also accept an electron to be converted to another nitroxide, 
undergoing a form of redox recycling238,239.  XJB has proven to be cytoprotective in disease 
states associated with oxidative stress, such as hemorrhagic shock, and mitigates apoptotic cell 
death in vitro240,241.  Its non-toxicity and ROS scavenging activity makes XJB an excellent 
candidate to study the role of intracellular oxidative stress in transplanted cell death.  
2.2 RATIONALE 
In the pursuit of cell-mediated therapies, primitive progenitor or stem cells are sought on the 
premise that differentiation into various lineages native to the targeted tissue or organ is 
necessary to promote regeneration.  However, our experience with myoblasts and MDSCs 
suggests that tissue specific differentiation potential is not sufficient.  In fact, it may not even be 
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necessary.  For example, in the case of MDSC transplantation following cardiac injury, MDSCs 
do not differentiate into cardiomyocytes however improved rates of angiogenesis and myocardial 
function are observed compared to myoblast transplantation43,242.  Clearly MDSCs can play a 
role in myocardial regeneration, however this indirect role suggests that multipotency is not the 
determinant of regeneration.  Perhaps it is the case that myoblasts could also promote similar 
levels of regeneration if they had similar post-transplantation survival rates as the MDSCs.   
Furthermore we demonstrated that when the stress defenses of MDSCs were impaired by 
treatment with DEM their capacity to improve post-infarction cardiac function was lost52.  These 
two results suggest that the improved regenerative capacity of the MDSC may be conferred by its 
improved post-injection survival rather than its multipotency.  We have shown previously that 
the increased regeneration index of MDSCs over that of myoblasts in skeletal muscle is 
accompanied by increased initial survival at 24hrs post-injection42. In this specific aim, we seek 
to determine whether the increased myogenic differentiation capacity is a result of its increased 
stress tolerance.  This has important implications for how we interpret in vitro differentiation 
capacity assays such as the myogenic differentiation index (MDI) or fusion index metric in vitro 
and regeneration capacity in vivo.  That is, the differentiation assay results may be confounded 
by different rates of cell survival in media conditions used to induce myogenic differentiation.  
We hypothesize that myoblasts are not in fact less myogenic, in the strict sense of myogenic 
differentiation potential, than MDSCs but are less capable of surviving in stress conditions 
relevant to the inflammatory and oxidative stress of the transplantation process. 
In vivo studies of murine MDSCs and early preplate cells (myoblasts) have shown a 
correlation between stress resistance and skeletal regeneration capacity52.  The argument for the 
link between regeneration capacity and stress resistance was further strengthened by the use of 
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diethyl maleate (DEM) in reducing the GSH levels of MDSCs, which effectively reduced the 
muscle regeneration capacity of MDSCs to that of myoblasts.  However, in the current study no 
corresponding anti-oxidant gain of function studies were performed in skeletal muscle.  N-
acetylcysteine (NAC), a cysteine containing antioxidant and GSH precursor, however was 
recently used to pretreat MDSCs transplanted in infarcted myocardium and shown to improve 
contractile function however no improvement in engraftment was observed130.  I proposed the 
use of XJB, a powerful anti-oxidant with high membrane permeability and low toxicity, to 
perform a corresponding gain of anti-oxidant function study in skeletal muscle. 
2.3 EXPERIMENTAL DESIGN 
Myogenic differentiation capacity was quantified in vitro by growing cells to 2D confluence in a 
flat bottom flask and exposing the colony to low serum media (2% horse serum in DMEM).  
After 4d cells were fixed and were characterized with immunohistochemical markers of 
myogenic differentiation such as myosin heavy chain.  Previous reports suggest that MDSCs 
demonstrate enhanced differentiation capacity in these serum starved conditions52.  We will 
determine if this differentiation assay may cause the loss of differentiation competent cells thus 
artificially deflating the MDI of myoblast populations (early preplate cells).  Equally important 
however is the differentiation capacity of these cells in stress conditions like those seen in tissue 
following transplantation, such as oxidative and inflammatory stress. Stress resistance of MDSCs 
and myoblasts in myogenic differentiation conditions were investigated in terms of survival, 
proliferation, and myogenic differentiation.  Stress conditions were modeled in vitro using 
hydrogen peroxide and TNF-α.  Proliferation and survival of myoblasts and MDSCs plated in a 
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24well plates were quantified using a live-cell imaging microscope243 in differentiation media.  
Well allocation and experimental flow is represented Figure 3 below. 
 Stress resistance of MDSCs and myoblasts when treated with the ROS scavenger XJB 
was also assessed in vitro.  Myogenic differentiation and survival capacity was quantified in 




Figure 3.  Experimental schematic of MDSC and myoblast survival during myogenic differentiation in vitro 
Proliferation rate and survival was quantified in conditions of low serum media (DM) and oxidative and 
inflammatory stress.   Myogenic differentiation under these conditions was quantified using the myogenic 
differentiation index (MDI) metric.  Myogenic differentiation and cell survival in conditions of oxidative and 
inflammatory stress was quantified in MDSCs pre-treated with the XJB anti-oxidant. 
 
The effect of XJB on the regenerative index MDSCs and myoblasts in the skeletal muscle 
was assessed in the mdx mouse (female.  Cells were expanded in vitro, trypsinized, and washed 
in cold PBS (4°C).  MDSCs and myoblasts (2 x 105 in 20µL of cold PBS) were injected 
intramuscularly in to the belly of the gastrocnemius muscle as described previously and shown in 
the schematic in Figure 4 below.  At 14 days the muscle was harvested and cryosectioned for 
immunohistochemical analysis. 
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Figure 4.  Experimental schematic to examine the regenerative capacity of anti-oxidant (XJB) treated muscle 
derived cells  
MDSCs and myoblasts (2 x 105 in 20µL of cold PBS) were injected intramuscularly in to the belly of the 
gastrocnemius muscle.  At 14 days the muscle was harvested and cryosectioned for immunohistochemical analysis. 
2.4 METHODS 
2.4.1 Murine MDSC and myoblast isolation via the preplate technique 
Murine myoblasts and MDSCs were isolated from the skeletal muscle of 3-wk-old C57BL/6J 
mice (The Jackson Laboratory, Bar Harbor, ME) as previously described using a modified 
preplate technique42,79. Muscle extracted from hindlimbs were minced into a slurry and 
enzymatically dissociated at 37°C in 0.2% collagenase-type XI (Sigma-Aldrich) for 1hr.  The 
cells were then incubated in dispase (2.4units/ml HBSS, GIBCO, Invitrogen) for 45min then for 
30min in trypsin-EDTA (0.1% in HBSS, GIBCO, Invitrogen).  The dissociated cells were 
filtered, centrifuged and resuspended in proliferation medium (PM) to initiate the preplate 
process. PM consists of 10% horse serum, 10% FBS, 0.5% chick embryo extract, and 1% 
penicillin–streptomycin (all reagents from GIBCO). 
 The preplate technique segregates muscle derived cell populations by how quickly they 
adhere to collagen-coated plates as described elsewhere41,79.  Briefly, cells are plated on collagen 
coated plates for a predetermined amount of time (PP1: 2hrs, PP2-PP6: 24hrs) at which point 
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non-adherent cells are collected, centrifuged and replated into the next preplate cycle.  Each 
preplate population has been previously characterized.  The PP1 population is populated 
predominantly with fibroblasts, whereas each subsequent preplate cycle is enriched with 
myogenic, desmin-positive cells 27,244,245.  MDSCs are isolated from long-term proliferating 
colonies of PP6. 
 Myoblasts were isolated from rapidly adhering cell fractions of the early preplate (EP) 
cycles (PP2-PP4).  “EPs” is an abbreviation for myoblasts isolated in this fashion.   MDSCs were 
isolated from the slowly adhering cell fraction of the late preplate cells (PP5-PP6).  All cells 
were cultured and expanded in PM as described previously79. 
2.4.2 Survival and proliferation of myoblasts and MDSCs in DM 
Time-lapse live cell microscopy was employed to monitor the rate of proliferation and survival 
in differentiation media (DM, 2% horse serum in DMEM) under conditions of oxidative (H2O2, 
250µM) and inflammatory stress (TNF-α, 2.5ng/ml)246,247.  Cells were plated in collagen-coated 
24-well plates at an initial density of 1000 cells/cm2 in proliferation medium for 6hrs or until 
adherence to the collagen coated flask bottom.  Each experimental group was represented in 
triplicate (three wells) and three areas were imaged in each well (n=9).  30min prior to placing 
the plate on live cell imaging incubator, the proliferation medium was exchanged with 
differentiation media under conditions of oxidative (250µM, H2O2) and inflammatory stress 
(2.5ng/ml, TNF-α), except in the case of one row of un treated PM which will serve as a control 
for proliferation and survival.  All wells were treated with 10µg/ml of propidium iodide whose 
intracellular accumulation, DNA intercalation, and fluorescence indicates cell death.  
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Proliferation was quantified by counting cells manually and survival was quantified by excluding 
cells that exhibit propidium iodide fluorescence in time-lapsed images as described previously 
(30min intervals in three 10x microscope fields over 48 hr)52. 
2.4.3 Myogenic differentiation assays 
The 24well plates were transferred to a (non-imaging) incubator for an additional 48hrs to allow 
for myogenic differentiation and fusion.  The cells were fixed in cold methanol (-20°C) and 
stained for myogenic differentiation.  Differentiation of myogenic cells into myosin heavy chain 
(fast) expressing myotubes were quantified using the MDI metric described previously.  Briefly, 
samples were blocked with 5% horse serum and incubated with monoclonal antibodies for MHC 
(Sigma; 1:300) followed by Cy3-conjugated anti-mouse antibodies.  Nuclei were stained blue by 
DAPI.  At least 200 cell nuclei were counted for each myogenic differentiation index 
measurement. 
2.4.4 In vitro proliferation capacity 
Time-lapse live cell microscopy was used to monitor the rate of proliferation of XJB treated cells 
under conditions of oxidative and inflammatory stress246,247.  Cells were plated in collagen-
coated 24well plates at an initial density of 1000 cells/cm2 in XJB treated (500nM) proliferation 
medium and incubated under normal conditions for 24hrs.  Stress conditions of oxidative 
(250µM, H2O2) and inflammatory stress (2.5ng/ml, TNF-α) in proliferation media were 
introduced to each well 30min prior to placing the plate on live cell imaging incubator.  
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Proliferation was quantified at 15min intervals in three 10x microscope fields over a 48 hr time 
period. 
2.4.5 In vitro myogenic differentiation capacity 
Cells were plated at 1000 cells/cm2 in 24-well plates for 2d in PM or until near confluence.  
During the last 24hrs of incubation PM was exchanged with XJB treated (500nM) PM for the 
antioxidant pretreatment prior to stress exposure.  XJB treated PM was then exchanged with 
differentiation media treated to simulate oxidative stress (25µM, 100µM, 250µM, and 500µM, 
H2O2) and inflammatory stress (1ng/ml, 2.5ng/ml, and 5ng/ml, TNF-α).  These media conditions 
were renewed daily in a similar protocol to previous experiments52.  After 4d the cells were fixed 
in cold methanol (-20°C), and the MDI were quantified as described previously. Briefly, samples 
were blocked with 5% HS and incubated with monoclonal antibodies for MHC followed by Cy3-
conjugated anti-mouse antibodies.  Nuclei were stained blue by 4, 6-diamidino-2-phenylindole 
(DAPI).  The myogenic differentiation index (MDI) was quantified by dividing the number of 
nuclei in MHC positive cells by the total number of nuclei.  At least 200 cell nuclei were counted 
for each MDI measurement. 
2.4.6 Skeletal muscle regeneration capacity 
XJB treated MDSCs and myoblasts were injected into the gastrocnemius muscles of female mdx 
mice(C57BL/10ScSn-DMDmdx/J, The Jackson Laboratory), aged 6–8 weeks (experimental 
groups include untreated, XJB-treated, NAC-treated, and PBS controls). The mdx mouse is a 
model of Duchenne muscular dystrophy, derived from a C57BL strain homozygous for a 
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spontaneous X-linked mutation of the dystrophin gene and lacks dystrophin protein 
expression248.  Cells cultured in collagen coated flasks were trypsinized, counted, washed in cold 
phosphate buffered saline (PBS), and resuspended in a cold PBS suspension of FluoSpheres, 2 x 
106 cells in 20ml of PBS, prior to injection.  At 14d post-injection, the gastrocnemius muscles 
were excised and frozen in 2-methyl-butane, cryosectioned (8µm sample thickness), and 
mounted on glass slides. Cryosectioned muscles were fixed in 5% formalin for 5 min and 
blocked in 5% horse serum in phosphate-buffered saline (PBS) for 1 h at room temperature 
(22°C).  Skeletal muscle sections were stained for dystrophin (1:300, Dys, Abcam) using 
protocols previously described in order quantify the regeneration index of the injection 
muscle249.  Fluorescence and bright field microscopy were performed using Nikon Eclipse E800 
microscope equipped with a Retiga Exi digital camera (QImaging). The animal research protocol 
was reviewed and approved by the Animal Research and Care Committee at the Children’s 
Hospital of Pittsburgh and University of Pittsburgh (0902596). 
2.4.7 Statistical Analysis 
Data are expressed as a mean with its standard deviation.  Direct comparisons between two cell 
populations were made using an unpaired, two-tailed Student’s t test, where statistical 
significance was determined at a level p < 0.05.  Comparisons of multiple groups were 
completed using one-way ANOVA followed by Tukey post-hoc comparisons. 
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2.5 RESULTS 
2.5.1 Proliferation and survival of myoblasts and MDSCs in differentiation media 
MDSCs exhibit increased oxidative and inflammatory stress resistance in vitro compared to 
myoblasts as illustrated in Figure 5 below.  Significant differences in normalized cell number 
were observed in MDSCs as a function of time over that of myoblasts in conditions of oxidative 
(H2O2, 250µM) and inflammatory stress (TNF-α, 2.5ng/ml).  This result confirms that the 
MDSC and myoblast populations exhibited differences in oxidative and inflammatory stress 
resistance52.  We then proceeded to study if similar differences in proliferative capacity would be 
observed in low serum differentiation media conditions. 
 
 
Figure 5.  Increased rate of proliferation of MDSCs in oxidative and inflammatory stress 
(a)  An increased rate of proliferation of MDSCs was observed when cultured in proliferation media (PM) treated 
with H2O2 (250µM) compared to early preplate myoblasts (EPs). (* indicates p<0.05)  (b)  A trend of increased 
proliferation rate of MDSCs in proliferation media treaded with TNF-α (2.5ng/ml) was observed however this 
difference was not statistically significant. 
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Proliferation rates of myoblasts and MDSCs in low serum (DM) and oxidative stress 
conditions were measured using time-lapse microscopy.  While no significant difference in 
MDSC proliferation was observed when grown in DM compared to PM, significant differences 
in proliferation were observed in myoblasts when grown in DM compared to PM as illustrated in 
Figure 6a and b.  It should be noted that no difference in MDSC and myoblast proliferation was 
observed when these two cell types were cultured in normal PM conditions, however significant 
differences in proliferative capacity when they were cultured in low serum DM conditions. 
Figure 6c and d illustrates that the increased proliferation rate of MDSCs in DM compared to 
myoblasts. 
 
Figure 6.  Loss of proliferation capacity in myoblasts in low serum and stress conditions 
(a)  No decrease in MDSC proliferation rate was observed in the first 48hrs of low serum (2% horse serum) 
differentiation media (DM) exposure compared to MDSCs grown in serum rich (10% fetal bovine serum + 10% 
horse serum) proliferation media (PM).  (b)  However a significant decrease in proliferation rate was observed in 
early preplate myoblasts (EPs) in DM compared to myoblasts grown in PM. (* indicates p<0.05)   (c,d)  While no 
significant difference in myoblast or MDSC proliferation was observed in PM conditions, a significant difference in 
proliferation rate in DM was observed. 
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The differences in proliferation capacity of myoblasts and MDSCs are a combination of 
differential survival and proliferation in low serum conditions.  To better understand the role of 
survival in this case, cell viability of myoblasts and MDSCs was quantified during DM exposure 
(2, 3, 4, and 6 days) by propidium iodide fluorescence detection using flow cytometry.  Figure 7 
illustrates an increase in MDSC viability compared to myoblasts in DM conditions suggesting 
that survival plays an important role in the difference in proliferation. 
 
 
Figure 7.  Survival of myoblasts and MDSCs in low serum media 
To clarify the role of survival in the proliferation capacity of MDSCs compared to myoblasts the rate of survival at 
different timepoints (2-6d) in differentiation media was quantified.  a) Cells were grown in 24 well plates for the 2, 
3, and 4d were trypsinized and incubated for 10minutes in propidium iodide.  Cell viability was quantified by flow 
cytometry.  d) This experiment was repeated to a 6d timepoint in triplicate, significant decreases in myoblast was 
observed when cultured in DM for 6days compared to MDSCs in DM as well as myoblasts in PM. 
 
An additional loss in proliferative capacity of myoblasts in DM was incurred by the 
addition of oxidative stress conditions (H2O2, 250µM), however not in inflammatory stress 
conditions (TNF-α, 2.5ng/ml). Figure 8 illustrates the loss in proliferative capacity of MDSCs 
and myoblasts under oxidative stress conditions.  Proliferation of myoblasts was essentially 
arrested by the addition of H2O2. Figure 9 on the other hand suggests that TNF-α has no 
additional impact on the proliferative capacity of myoblasts in DM conditions.  
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Figure 8.  Additional loss in proliferative capacity of myoblasts in DM under oxidative stress conditions 
(a-b)  Oxidative stress challenge under DM conditions exacerbated the loss in proliferation rate under DM 
conditions for both MDSCs and myoblasts (EPs). (* indicates p<0.05) 
 
 
Figure 9.  No additional loss in proliferative capacity of myoblasts in conditions of inflammatory stress 
(a-b)  In contrast to oxidative stress challenge under DM conditions, no additional loss in proliferative capacity was 
observed in inflammatory stress (TNF-α, 2.5 ng/ml). 
2.5.2 Improved differentiation capacity of XJB treated cells in oxidative stress 
We observed significant increases (p<0.05) in myogenic differentiation capacity of MDSCs in 
oxidative stress when the cells were pretreated XJB prior to hydrogen peroxide exposure. Figure 
10 illustrates significant increases in differentiation capacity of MDSCs pretreated with 500nM 
XJB prior to being exposed to low serum DM and oxidative stress (H2O2) conditions.   
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Figure 10.  Improved myogenic differentiation capacity of MDSC pretreated with antioxidant XJB 
Pre-treatment of MDSCs improved the myogenic differentiation efficiency under conditions of oxidative stress 
(H2O2).  Improvements in differentiation were observed up to a concentration of 500nM, which served as the XJB 
pre-treatment concentration for the remainder of the experiments.  (* indicates p< 0.05). 
 
Increased myogenic capacity of XJB treated cells in low serum DM and oxidative stress 
conditions was found to correlate with MDSC survival as well, as illustrated in Figure 11 below.  
Experimental conditions in this case were nearly identical to those represented in Figure 10, 
however in addition cell survival in each case was quantified and normalized by cell numbers in 
MDSCs in DM conditions without XJB pre-treatment or oxidative stress challenge.  A strong 
correlation of differentiation capacity with cell survival was observed (Figure 11d).  That is, not 
only did fewer cells survive DM and oxidative stress conditions but differentiation capacity of 
those surviving was also impaired.   
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 Figure 11.  Correlation of myogenic differentiation of MDSCs with survival 
(a-b)  Immunohistology of myosin heavy chain (MHC-red) expressing MDSCs in differentiation media and 
oxidative stress (H2O2) conditions for 4d.  Nuclei are stained blue via DAPI.  Increased rates of MHC+ cell 
differentiation was observed when MDSCs were pre-treated with XJB (500nM) prior to differentiation media 
conditions. (c)  The rate of myogenic differentiation was quantified using the myogenic differentiation metric 
(MDI).  XJB pre-treatment improves myogenic differentiation capacity of MDSCs in oxidative stress (250-500µM).   
(* indicates p< 0.05).  (d)  The differentiation capacity of MDSCs correlated positively with measurements of cell 
survival in DM conditions (r2=0.88594). 
2.5.3 Skeletal muscle regeneration capacity of XJB treated cells 
MDSCs and myoblasts treated with XJB (500nM) prior to being injected in to the gastrocnemius 
muscle of female mdx mice demonstrated a trend of increased regeneration index over that of 
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untreated cells and DEM treated MDSCs.  The skeletal muscle regeneration index is plotted in 
Figure 12.  Differences in the regeneration index however did not rise to the level of significance 
in either cell type however the greatest mean improvement in RI was observed in myoblasts.  
This improvement was just shy of the level of statistical significance (p=0.07). 
 
Figure 12.  Skeletal muscle regenerative capacity of myoblasts and MSDCs with antioxidant pretreatment 
(a)  Early preplate myoblasts (EPs) pretreated with XJB anti-oxidant (500nM) prior to intramuscular injection into 
the mdx mouse gastrocnemius induced greater muscle regeneration than untreated and NAC (n-acetylcysteine, 
10mM) pretreated myoblasts, although this increase was not found to be statistically significant.  (b)  A similar trend 
of increased skeletal muscle regeneration was observed in XJB pre-treated MDSCs.  However, again, this increase 
was not statistically significant. 
2.6 DISCUSSION 
Myoblast differentiation is typically induced in medium with a low concentration of mitogens, 
such as low serum or serum-free differentiation medium250-252.  On exposure to low serum 
conditions myoblasts rapidly and permanently withdraw from the cell cycle and initiate 
myogenic differentiation and fusion programs.  Wang and Walsh studied the behavior or C2C12 
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myoblasts under low serum conditions253.  They observed that of those C2C12 cells that 
underwent cell cycle arrest, a large proportion of these cells proceeded to apoptose (20-30%) in 
low serum conditions.  This process of cell death began at 24hrs and peaked at 48hrs253.   Of 
those cells that successfully underwent differentiation and fusion these cells appeared to be quite 
apoptosis resistant, surviving up to 2 weeks in low serum conditions.  This suggests that 
myoblasts undergoing differentiation proceed through a time window of vulnerability however 
once differentiated the cells resist apoptosis.  Shen et al. confirmed this result by further mapping 
pro-apoptotic gene upregulation in low serum conditions254.   This apoptosis resistant state at the 
time was correlated with the expression of cyclin dependent kinase (CDK) inhibitors p21 and 
p16, retinoblastoma (Rb) protein, a tumor suppressor with anti-proliferative activity, and Akt, a 
serine threonine kinase with anti-apoptotic properties255-257. However, apoptosis during 
myogenic differentiation may also be mitigated by suppression of MyoD one the master 
regulators of myogenic differentiation, which appears to upregulate anti-apoptotic genes, to 
repress pro-apoptotic genes and to improve myoblast survival258. 
 Mammalian muscle differentiation proceeds though a sequential expression of muscle 
regulatory factors including Myf5, MyoD, myogenin, and Mrf4, which control expression of 
differentiation specific genes such as myosin heavy chain and creatine kinase102,259.   Myogenin 
in particular appears to mark the transition from a proliferative myoblast to a fully differentiated 
and post-mitotic myocyte260.  At this point expression of p21 and Rb appears to induce this loss 
of proliferative capacity and prevent cell cycle reentry255,256.  However in the absence of p21 
expression significantly increased rates of apoptosis were observed253.  During primary myoblast 
differentiation, expression of S phase proteins such as the cyclins D1 and E, auroraB, survivin, 
anilin and Emi1/FBXO5 are swiftly downregulated indicating that differentiation induces a 
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decidedly post-mitotic state261.  Furthermore these proteins were shown to be re-expressed 
indicating cell cycle reentry when the myocytes were forced to de-differentiate by suppressing 
Rb and ARF261. 
 Studies by Walsh and Shen and others suggest that myoblasts in low serum conditions will 
either apoptose or exit the cell cycle to undergo differentiation and fusion, however the present 
study suggests that MDSCs do not reach such a dichotomous checkpoint in these 
conditions253,254.  The present study demonstrated that MDSCs do not undergo a dramatic shift in 
their proliferative capacity when cultured for 48hrs in low serum media.  This is in contrast to 
similar studies performed on C2C12 and L6 rat myoblasts. That their proliferative capacity in 
low serum conditions is significantly greater than early preplate myoblasts suggest they may not 
be subject to the same checkpoints that force myoblasts to exit the cell cycle.  MDSCs are also 
able to withstand oxidative stress in theses low-serum conditions at greater rates than myoblasts 
in terms of their proliferation and myogenic differentiation capacity.  The increased proliferative 
capacity of MDSCs compared to myoblasts in low serum conditions that also drive 
differentiation may confer their increased myogenic potential42,52,79.  This increased oxidative 
stress resistance capacity of MDSCs in low-serum conditions compared to myoblasts further 
supports our earlier work that increased cell competence in conditions of oxidative stress 
encountered in vivo following intramuscular transplantation likely drives the increased muscle 
regenerative capacity of MDSCs52. 
 Previously we observed increased stress resistance in MDSCs that was conferred by 
increased intracellular anti-oxidant levels such as reduced glutathione and super-oxide dismutase 
compared to myoblasts52.  We proceeded to study whether increased stress resistance and muscle 
regeneration could be induced by treating MDSCs with an exogenous anti-oxidant such as n-
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acetylcysteine or XJB130.   In a previous study by Drowley et al., we observed an increase in 
regenerative capacity following NAC treatment of MDSCs and in the current study we observed 
non-significant trends of increased regenerative capacity in XJB treated MDSCs as well as 
myoblasts130.  That the improvements in skeletal muscle regeneration appeared to be greater in 
myoblasts suggests that there may be diminishing returns in increasing anti-oxidant capacity. 
Perhaps once a certain anti-oxidant level is reached further intracellular reduction state is not 
protective but may even begin to affect the normal ROS signaling of the cell. 
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3.0  SPECIFIC AIM 2: TO DETERMINE THE MUSCLE REGENERATION 
CAPACITY OF A SUB-POPULATION OF MURINE PREPLATE CELLS WITH 
ELEVATED STRESS RESISTANCE 
3.1 BACKGROUND 
3.1.1 Muscle derived stem cell isolation via a modified preplate technique 
Numerous techniques of myoblast isolation from skeletal muscle biopsies have been identified, 
however one of the simplest is the preplate technique79,244,245.  The technique utilizes the 
observation that myoblasts do not adhere to collagen coated tissue culture flasks as rapidly as the 
numerous fibroblasts and endothelial cells that are found in whole muscle digests.  Therefore less 
rapidly adhering myoblasts could be segregated by collecting non-adhered cells after a few hours 
of culture.  Our group found that this technique could be extended to six days or more to isolate 
multiple fractions of myogenic cells including the muscle derived stem cell42.  MDSCs have 
been shown to differentiate into musculoskeletal tissues such as bone, cartilage, and skeletal 
muscle, in addition to endothelial, neural and hematopoietic tissues42,77,78,80,82-84.  Perhaps more 
important than MDSC multipotency, however is the increased rate of survival and engraftment in 
skeletal muscle when compared to myoblasts.   
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3.1.2 Elevated oxidative stress resistance of MDSCs 
We have shown that muscle derived stem cells (MDSCs) induce greater skeletal muscle 
regeneration than myoblasts largely due to their increased oxidative stress resistance41-43,52.  It is 
the oxidative and inflammatory environment that the cell population encounters following 
transplantation that causes a precipitous cell loss and is the greatest limitation in myogenic cell 
therapy9,16,47,202. These conditions can be partially overcome by injecting a myogenic cell 
population with increased oxidative stress resistance or anti-oxidant capacity, an attribute that we 
have characterized in muscle derived stem cells.  When we decreased their GSH anti-oxidant 
levels using diethyl maleate, we observed a commensurate decrease in engraftment and skeletal 
muscle regeneration52.  On the other hand when we increased the GSH levels of MDSCs using n-
acetylcysteine we observed an increase in regeneration capacity262.  We therefore hypothesized 
that muscle regenerative capacity may be due primarily to the transplanted cells capacity for 
oxidative and inflammatory stress resistance rather than tissue specific differentiation capacity.  
In fact, some groups have suggested that increased stress resistance may be a primary 
characteristic of stemness154,263-265. 
 Numerous myogenic progenitors have been isolated for cell therapy such as 
myoblasts245, muscle derived stem cells42, side-population cells65, Sk-DN/Sk-34 cells66, and 
CD133+ progenitors67,68.  Prospective isolation of perivascular cells such as pericytes72, 
mesangioblasts73, endothelial and myo-endothelial74 cells based on surface markers such as 
CD144, CD146, CD56, and CD34 have also yielded myogenic differentiation in vitro and in 
vivo69,74-76.  However we are currently focused on the isolation of stem cells based on their 
behavior and survival characteristics, specifically on elevated oxidative and inflammatory stress 
resistance52.  It is this behavior that we believe may be the primary determinant of myogenic cell 
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therapy.   In the current study, we sought to isolate myogenic progenitors with enhanced stress 
resistance by their elevated expression of aldehyde dehydrogenase, an intracellular marker 
increasingly being used to isolate primitive progenitors from multiple tissues. 
3.1.3 Aldehyde dehydrogenase as a marker for early progenitor status and enhanced 
stress resistance 
Recently elevated aldehyde dehydrogenase has been shown to be a marker of early progenitor 
status in hematopeitic180,181, mesenchymal182, endothelial183, neural184,185, and recently skeletal 
muscle186 populations, as well as marker of cancer stem cells or metastasis competent tumor 
cells152,266-269.   Many of these somatic and cancer stem cells have also be shown to have 
increased anti-oxidant capacity79,226.   For example, hematopoietic stem cells may upregulate 
FoxO (Forkhead O) transcription factors, downstream targets of the PI3K-AKT pathway and 
regulators of the oxidative stress response, which include induction of MnSOD, catalase, and 
GADD45190-194. Similar properties of increased expression of free radical scavenging systems 
and decreased levels of reactive oxygen species is observed in epithelial breast cancer stem 
cells195,266,270.  Endothelial progenitors isolated from umbilical cord blood have been shown to 
have elevated MnSOD levels that significantly increase their oxidative stress resistance and 
therefore in treating tissue ischemia148,196. 
In the current study, ALDHhi and ALDHlo subpopulations of skeletal muscle derived cells 
were isolated from cultured murine and human skeletal muscle by fluorescence activated cell 
sorting (FACS).  The stress resistance and muscle regeneration capacity of these ALDH sorted 
subpopulations were examined in vitro and in vivo. We hypothesized that increased ALDH 
activity may identify myogenic progenitors with increased oxidative and inflammatory stress 
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resistance.  As discussed previously, we believe this increased stress resistance may confer an 
increased engraftment and muscle regeneration capacity over ALDHlo and unsorted muscle 
derived populations.  Thus, ALDH may be used as a marker of myogenic cells of increased 
stress resistance capacity and therefore an excellent candidate for myogenic cell therapies. 
3.2 RATIONALE 
We sought to isolate myogenic progenitors with elevated anti-oxidant capacity or stress 
resistance based on a novel marker of early progenitor status: elevated aldehyde dehydrogenase.  
ALDHhi and ALDHlo populations were isolated from murine preplate cells: myoblasts and 
MSDCs.  We hypothesized that increased ALDH activity may identify myogenic progenitors 
with increased stress resistance thus conferring an increased engraftment and muscle 
regeneration capacity in vivo over the ALDHlo and unsorted preplate populations. 
3.3 EXPERIMENTAL DESIGN 
ALDHhi and ALDHlo sub-populations myoblasts and MDSCs were isolated using fluorescence 
activated cell sorting (FACS).  The stress resistance of ALDH sorted cells were then 
characterized in terms of their proliferation and differentiation potential in conditions of 
oxidative (H2O2) and inflammatory stress (TNF-α).  Their intracellular anti-oxidant levels in 
terms of glutathione and superoxide dismutase were also evaluated.  The experimental schematic 
to study this in vitro stress resistance capacity is illustrated in Figure 13. 
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Figure 13.  Experimental schematic to study stress resistance capacity of ALDH sorted murine preplate cells 
ALDHlo and ALDHhi subpopulations of muscle derived cells (MDCs) were isolated by fluorescent activated cells 
sorting (FACS).  Proliferative and myogenic differentiation capacity with were quantified in conditions of oxidative 
(H2O2) and inflammatory stress (TNF-α, not shown in schematic).  Intracellular anti-oxidant levels, specifically 
reduced glutathione (GSH) and super-oxide dismutase (SOD) were assessed in each ALDH sorted subpopulation of 
MDCs. 
 
The skeletal muscle regeneration capacity of the ALDHhi and ALDHlo subpopulations of 
murine preplate cells was evaluated in the gastrocnemius of an mdx mouse model.  To conform 
to relevant studies of murine MDSCs, ALDHhi and ALDHlo subpopulations were transplanted 
into female mdx mice aged 6-8weeks for a period of 14d, as depicted in Figure 14 below52. 
 
Figure 14.  Experimental schematic to characterize the muscle regeneration capacity of ALDH sorted murine 
pre-plate cells 
ALDHlo and ALDHhi cells were injected directly into the gastrocnemius muscles of female mdx mice aged 6-8 
weeks.  The regeneration index was quantified via histological evaluation of the rate of dystrophin expression of 
cryosectioned muscle 14 days post-injection. 
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3.4 METHODS 
3.4.1 Murine myoblast and MDSC isolation via the preplate technique 
Murine MDSCs and myoblasts are isolated from the skeletal muscle of 3-wk-old C57BL/6J mice 
as previously described using the modified preplate technique42,79.  MDSCs were isolated from 
expansion of the sixth preplate (PP6) while early preplate myoblasts were isolated from preplates 
2 through 4 (PP2-PP4).  All cells were cultured and expanded in PM as described previously79.  
When applying the preplate technique to ALDH sorted cells (as shown in Figure 1h), the 
digestion process was identical to that described above; however, the digested muscle cells were 
sorted for ALDH activity using FACS prior to the performing the preplate protocol. 
 
3.4.2 Flow cytometric analysis and sorting by ALDH activity 
Cultured murine preplated cells were trypsinized, washed in cold PBS, and counted using a 
hemocytometer.  Cells (106) of each population were resuspended in Aldefluor buffer, which 
contains an ABC transport inhibitor that prevents efflux of the aldefluor dye, and incubated at 
37°C with BAAA according to the manufacturer’s instructions (Aldagen Inc, Durham, NC).  
Cells were washed in Aldefluor buffer and maintained in 4°C throughout the cell sorting process.  
ALDH activity was assessed using the FL1 channel of a BD FACSAria Cell Sorting System and 
FACSDiva software (version 6.1.2) (Becton, Dickinson and Company, San Jose, CA).  Collected 
cells were gated on their fluorescence intensity, which corresponds to their ALDH activity 
levels, as well as low side scatter (SCClo).  Sorted cells were recaptured in cold (4°C) 
  56 
proliferation media and immediately plated in collagen coated flasks and normal incubation 
conditions (5% CO2 at 37°C). 
3.4.3 In vitro proliferation capacity 
Time-lapse live cell microscopy was employed to monitor the rate of proliferation under 
conditions of oxidative and inflammatory stress246,247.  Sorted human muscle derived cells were 
plated in collagen-coated 24-well plates at an initial density of 1000 cells/cm2 in PM and 
incubated under normal conditions for 24hrs.  The media was exchanged with proliferation 
media treated to simulate oxidative (250µM, H2O2, Sigma-Aldrich) and inflammatory stress 
(2.5ng/ml, TNF-α, both mouse and human recombinant, R&D Systems) and immediately placed 
in live cell imaging incubator.  Cells were imaged at 30min intervals in three 10x microscope 
fields per well over a 48 hr time period under normal incubation conditions (5% CO2 at 37°C). 
3.4.4 In vitro muscle differentiation capacity 
The capacity of ALDH sorted cell populations to differentiate into MHC expressing cells under 
varying conditions of oxidative and inflammatory stress was quantified in vitro using a myogenic 
differentiation index (MDI) metric.  Cells were plated at 1000 cells/cm2 in 24-well plates for 2d 
in PM or until near confluence.  PM was then exchanged for differentiation media (DM; 2% HS, 
1% P/S in DMEM) treated to simulate oxidative stress (25µM, 100µM, 250µM, and 500µM, 
H2O2, Sigma-Aldrich) and inflammatory stress (1ng/ml, 2.5ng/ml, and 5ng/ml, TNF-α, R&D 
Systems).  The media was exchanged daily to maintain constant stress levels52.  Cells were 
allowed to differentiate and fuse for 4d then fixed with cold methanol (-20°C).  The MDI metric 
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is calculated as a ratio of MHC expressing cells to the total number of cells detected following 
fixation.  (Immunohistochemical staining methods for MDI measurement is described in the 
following “Immunohistochemistry” methods section. 
3.4.5 Intracellular antioxidant capacity 
The antioxidant capacity was measured in terms of the activity of the major intracellular anti-
oxidant molecules: reduced glutathione (GSH) and superoxide dismutase (SOD).  Levels of GSH 
were measured colorimetrically (Calbiochem, 354102) using a spectrophotometer (TECAN 
Infinite M200, Männedorf, Switzerland).  GSH detection is mediated by capture of all thiol 
mercaptans (RSH) from mechanically homogenized cells into thioethers by 4-chloro-1-methyl-  
7-trifluromethyl-quinolinium methylsulfate followed by the formation of a chromophoric thione 
in those GSH specific thioethers using NaOH.  GSH levels were quantified by chromophoric 
thione absorbance at 400nm.  Total activity of SOD was measured using a colorimetric assay 
(Chemicon, Temecula, CA; APT290).  SOD levels of chemically lysed cells (10 mM Tris, pH 
7.5, 150mN NaCl, 0.1 mM EDTA, and 0.5% Triton X-100) were measured using a 
xanthine/xanthine oxidase system in which superoxide-chromagen absorbance (490nm) is 
lowered by the presence of SOD. 
The intracellular antioxidant levels of ALDHlo and ALDHhi myoblasts were modified by 
a chemical antioxidant (XJB-5-131, generously donated by Prof. Peter Wipf at the University of 
Pittsburgh) and pro-oxidant (diethyl maleate (DEM), Sigma-Aldrich).  XJB is a membrane 
permeable, mitochondrial targeted nitroxide anti-oxidant that has proven to be cytoprotective in 
disease states associated with oxidative stress, such as hemorrhagic shock, and mitigates 
apoptotic cell death in vitro240,241; whereas DEM, is a chemical that conjugates and inactivates 
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GSH thus decreasing the cell’s capacity to resist oxidative stress271.  To examine the role of 
antioxidant levels in ALDH sorted myoblasts, ALDHlo myoblasts were pretreated with 500nM 
XJB in PM for 2hrs prior to exposure to oxidative stress (250µM H2O2 in PM) conditions.  
ALDHhi myoblasts were pretreated with 50µM DEM for 2hrs prior to exposure to oxidative 
stress (250µM H2O2 in PM) conditions.  In both cases the myoblasts were washed in PBS prior 
to stress exposure to insure all active antioxidants were intracellular.  The rates of proliferation 
and survival of these pretreated myoblasts were quantified using a live cell imaging robot 
(Kairos Instruments LLC, Pittsburgh, PA) as described previously. 
To examine the role of ALDH in the anti-oxidant capacity of ALDH sorted myoblasts a 
potent ALDH inhibitor, diethylaminobenzaldehyde, was used.  Pretreatment of ALDHhi 
myoblasts with 200µM of DEAB in PM was used 24hrs prior to oxidative stress exposure.  A 
concentration of 200µM DEAB was maintained during the oxidative stress exposure to maintain 
ALDH inhibition throughout the experiment.  The rates of proliferation and survival were 
quantified using the live cell imaging robot. 
3.4.6 Skeletal muscle regeneration capacity 
Skeletal muscle regeneration capacity of ALDH sorted myogenic cells was quantified using the 
regeneration index metric as previously described42,52,81.  Briefly, the number of dystrophin 
positive myofibers per cryosection per 105 cells injected is recorded.   ALDH sorted murine cells 
were injected into the gastrocnemius muscles of female mdx mice (C57BL/10ScSn-DMDmdx/J, 
The Jackson Laboratory), which is a murine model of Duchenne muscular dystrophy using a 
protocol previously described52,248.  The mdx mouse is a C57BL strain homozygous for a 
spontaneous X-linked mutation of the dystrophin gene and lacks dystrophin protein 
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expression248.  Animals were sacrificed 14d following injection.  All gastrocnemius muscles 
were excised and frozen in 2-methyl-butane, cryosectioned (8µm), and mounted on glass slides. 
The animal research protocol was reviewed and approved by the Animal Research and Care 
Committee at the Children’s Hospital of Pittsburgh and University of Pittsburgh (0902596). 
3.4.7 Immunohistochemistry 
Differentiation of myogenic cells into MHC expressing cells in vitro was quantified using the 
MDI metric described previously.  Briefly, samples were blocked with 5% HS and incubated 
with monoclonal antibodies for MHC (Sigma; 1:300) followed by Cy3-conjugated anti-mouse 
antibodies.  Nuclei were stained blue with 4, 6-diamidino-2-phenylindole (DAPI, Sigma; 100 
ng/ml, 1:1000).  The MDI is defined as the number of nuclei within  MHC–expressing cells 
divided by the total number of nuclei272.  At least 200 cell nuclei were counted for each MDI 
measurement. 
All murine skeletal muscle tissue samples were frozen in 2-methylbutane cooled in liquid 
nitrogen, then stored at –80°C. 8µm cryosections were fixed in 5% formalin for 2 min and 
blocked in 5% donkey serum for 1h.  Skeletal muscle sections were stained for dystrophin (DYS) 
using an anti-dystrophin primary antibody (1:300, Rabbit Anti-DYS, Abcam Ab15277) and a 
secondary anti-rabbit antibody (1:500, Donkey anti-Rabbit, Molecular Probes A21207) using a 
protocol previously described249. Nuclei were stained with DAPI.  Fluorescence and brightfield 
microscopy was performed using a Nikon Eclipse E800 microscope (Melville, NY) equipped 
with a Retiga Exi digital camera (QImaging) and Olympus FV 500 confocal scanning 
microscope.  All images were acquired and analyzed using Northern Eclipse software (version 
6.0; Empix Imaging). 
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3.4.8 Osteogenic and chondrogenic differentiation capacity 
ALDHhi, ALDHlo and unsorted cells were prepared in pellet form (2.5 × 105 cells) or as a 
monolayer (1.5 × 104 cells/well in 12 well plates). For osteogenesis, murine myoblasts were 
plated on collagen-coated 12 well plates and maintained for 4d in osteogenic media (Lonza, 
Walkersville, MD), which included dexamethasone, glutamine, ascorbate, 
penicillin/streptomycin (P/S), β-glycerophosphate and bone morphogenic protein-4 (50 ng/ml).  
The cells were stained for alkaline phosphatase following the manufacturer’s instructions 
(Sigma-Aldrich, 86C-1KT).  Chondrogenesis of murine myoblasts was studied by culturing the 
cells in a pellet culture by incubating the cell pellets for 21d in chondrogenic media (Lonza, 
PT3003), which contains dexamethasone, ascorbate, ITS+, P/S, sodium pyruvate, proline, 
glutamine and TGF-β3 (10ng/ml) (Lonza, PT4124).  All pellets were fixed in 10% formalin for 
24hrs followed by dehydration, paraffin embedding, sectioning, and Alcian blue staining. 
3.4.9 Statistical Analysis 
Data are expressed as a mean with its standard deviation.  Direct comparisons between two cell 
populations were made using an unpaired, two-tailed Student’s t test, where statistical 
significance was determined at a level p < 0.05.  Comparisons of multiple groups were 
completed using one-way ANOVA followed by Tukey post-hoc comparisons. 
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3.5 RESULTS 
3.5.1 Flow cytometric sorting of murine preplate cells 
Cells with elevated ALDH levels become fluorescent when exposed to boron-dipyrromethene 
(BODIPY) labeled amino acetaldehyde (BAAA) (Aldefluor, StemCell Technologies) can be 
isolated using fluorescence activated cell sorting (FACS).  The non-polar BAAA diffuses freely 
into the cytoplasm and is converted by ALDH1A1 to the negatively charged BIODIPY-
aminoacetate, which trapped in the cytoplasm causes the cell to fluoresce with an emission peak 
at 513nm 189.  Cells, of low side scatter, that were significantly brighter than the DEAB inhibited 
population were deemed ALDHhi and isolated from heterogeneous populations of murine and 
human muscle derived cells. 
In order to isolate ALDHloSSClo and ALDHhiSSClo sub-populations of cultured muscle 
derived cells, cells were treated with Aldefluor.  ALDHhi subpopulations were isolated from 
murine muscle cells segregated by the preplate technique, which included rapidly adhering 
myoblasts and slowly adhering MDSCs.  The gating of ALDHhi and ALDHlo populations was 
determined by the low sidescatter extremes of the DEAB inhibited ALDH fluorescence (Figure 
15a).  ALDHlo and ALDHhi myoblasts represented roughly 1% and 3-5% of the total myoblast 
population respectively (Figure 15b) when dead cells were excluded using propidium iodide 
uptake (Figure 15c).  An ALDH fluorescence frequency histogram illustrates the enrichment of 
ALDHhi cells in murine MDSCs compared to myoblasts in Figure 15e.  That is, MDSCs were 
shown to have a significantly elevated mean ALDH fluorescence when compared to murine 
myoblasts.  In addition MDSCs appear to have a decreased ALDH distribution range indicating 
less heterogeneity in ALDH expression than murine myoblasts.   It should also be noted that we 
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observed increased cell viability in ALDHhi cells compared to ALDHlo cells immediately 
following FACS isolation.  That is, the mechanical stress of the cell segregation process of flow 
cytometry seemed to have more deleterious effect on the ALDHlo cells compared to the ALDHhi 
cells in terms of survival. 
 
 
Figure 15.  FACS analysis of murine myoblasts and MSDCs 
Isolation of ALDHlo and ALDHhi subpopulations from cultured early preplate myoblasts was performed using 
FACS.  (a)  Dead cells were excluded from the isolation by detection of nuclear propidium iodide fluorescence.  (b-
c)  ALDHhi SCClo (high ALDH activity, low side scatter) cells were isolated from a heterogeneous population of 
myoblasts using DEAB, a potent inhibitor of ALDH, as a gating control.  (d-e)  Measurement of the FITC signal 
intensity of Aldefluor stained murine myoblasts and MDSCs demonstrated a shift in the distribution of signal 
intensity between the two populations, shown in (f), suggesting a increase in median ALDH activity in MDSCs 
compared to myoblasts.   The shaded red overlay is meant to emphasize the trend of increasing stress resistance 
between myoblasts and MDSCs. 
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3.5.2 Enrichment of ALDHhi cells in slowly adhering preplate cells 
In order to determine whether the preplate process may select for ALDHhi cells or enrich murine 
muscle derived cells with cells with elevated ALDH levels, Aldefluor intensities were measured 
in successive preplate cycle populations, illustrated in Figure 16a,b.   Despite an elevated median 
ALDH level and ALDHhi proportion observed in PP1, a overall trend of increasing ALDH 
intensity and proportion of ALDHhi cells was observed with each preplate cycle.  This result 
supports the previous observation of Figure 15 (d-f) that suggests an overall increase in ALDH 
levels in MDSCs (derived from PP6) and myoblasts (PP2-PP4). 
 
 
Figure 16.  ALDH activity of murine muscle preplate cells via FACS 
FACS analysis of preplated cells derived from murine skeletal muscle (PP1-PP5) indicates increasing ALDH 
activity with successive preplate cycles. (a)  Median FITC intensity measurements of Aldefluor stained preplate 
cells was measured by flow cytometry.  A trend of increasing ALDH activity with preplate cycle was observed.  (b)  
The percentage of ALDHhi cells in each preplate was plotted as a function of preplate cycle.  A trend of increasing 
proportion of ALDHhi cells was observed as a function of preplate cycle. 
 
To verify this observation of enrichment of ALDHhi cells in later preplate cycles, freshly 
dissociated murine skeletal muscle cells were sorted into ALDHhi and ALDHlo sub-populations 
by FACS.  These populations were then immediately subjected to the modified preplate process 
described previously.  The ALDHlo sub-population of cells not only suffered more cell death as a 
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result of the FACS process, observed in previous experiments as well, but of those cells that 
survived adhered rapidly to collagen-coated flasks.  As depicted in Figure 17 below, ALDHlo 
cells could only be preplated for two iterations over a 2hr period (PP1 to PP2).  Although three 
cells were found in the fourth preplate this did not constitute a significant population, particularly 
given that no PP3 cells were observed.  On the other hand the ALDHhi subpopulation of muscle 
derived cells yielded a robust population of cells to preplate 4.  While the ALDHhi population did 
not yield any cells to preplate 6 (PP6) unlike the unsorted muscle derived cells, these cells were 
subjected to the high velocity mechanical stress of fluorescence activated cell sorting and likely 
suffered a loss in viability. 
 
Figure 17.  ALDHhi muscle cells yield later preplate populations 
Later preplate cycles were achieved using ALDHhi cells (PP4) compared to ALDHlo cells (PP2).  MDSC equivalent 
preplate cells (PP5-PP6) were not observed following ALDH sorting likely due to loss of viability during the 
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3.5.3 Stress resistance of ALDH sorted myoblasts 
Myoblasts isolated using the preplate technique have been characterized as a heterogeneous 
population in various states of quiescence, activation, and differentiation27,42,81.  We therefore 
hypothesized that we may observe heterogeneity in their ALDH expression. Following FACS 
isolation of ALDHlo and ALDHhi subpopulations, we quantified the oxidative (hydrogen 
peroxide or H2O2) and inflammatory (TNF-α) stress resistance during proliferation and 
myogenic differentiation.  Hydrogen peroxide is a strong oxidant that is formed by the 
dismutation of superoxide and freely diffuses across the cell membrane.  TNF-α on the other 
hand is an acute phase cytokine that has been shown to inhibit myogenic differentiation via NF-
κB induction, promote caspase mediated apoptosis, and induce reactive oxygen species 
accumulation in mitochondria273,274.  Both H2O2 and TNF-α are active during inflammation114.  
 Following FACS isolation of ALDHhi and ALDHlo subpopulations of murine myoblasts, 
oxidative (H2O2) and inflammatory (TNF-α) stress resistance during proliferation was quantified 
(Figure 18a and b). The proliferation rate of ALDHlo and ALDHhi subpopulations of murine 
myoblasts was quantified using live cell imaging microscopy in conditions of oxidative (250 
µM, H2O2) and inflammatory (2.5 ng/ml, TNF-α) stress. A significant proliferation advantage of 
ALDHhi cells is observed in the murine myoblasts when normalized cell numbers are compared 
to ALDHlo cells as a function of time. 
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Figure 18.  ALDH sorted myoblast proliferation in oxidative and inflammatory stress 
(a)  A significantly increased rate of proliferation of ALDHhi early preplate myoblasts compared to 
ALDHlo myoblasts was observed in conditions of oxidative stress (H2O2, 250µM) (* indicates p < 0.05).  
(b) Similarly ALDHhi myoblasts demonstrated elevated proliferative capacity in inflammatory stress 
conditions (TNF-α, 2.5ng/ml). 
 
 The myogenic differentiation index (MDI), a measure of the proportion of cells expressing 
myosin heavy chain (MHC), of ALDHhi and ALDHlo murine and human muscle derived cells 
was quantified in conditions of oxidative (H2O2) and inflammatory (TNF-α) stress.  Similarly, a 
significantly increased number of myosin heavy chain expressing cells was observed in ALDHhi 
murine myoblasts compared to ALDHlo myoblasts (Figure 19). 
 
  67 
 
Figure 19. Myogenic differentiation of ALDH sorted myoblasts in conditions of oxidative and inflammatory 
stress 
(a) ALDHlo and ALDHhi myoblasts underwent myogenic differentiation by fusing into MHC+ myotubes (red) under 
oxidative stress conditions (250µM). Nuclei are stained with DAPI (blue).  (b) Significantly increased myogenic 
differentiation indices (MDI) were observed (p < 0.05) in ALDHhi myoblasts at several concentrations of oxidative 
stress (0, 250 and 500µM) when compared to ALDHlo myoblasts.  (c) Significantly increased myogenic 
differentiation indices (MDI) of ALDHhi cells were observed under all inflammatory stress conditions when 
compared to ALDHlo myoblasts. 
 
3.5.4  Skeletal muscle regeneration capacity of ALDH sorted myoblasts 
ALDHhi and ALDHlo murine myoblasts were injected intramuscularly into the gastrocnemius of 
mdx mice to determine the degree of muscle regeneration.  Muscles were excised and frozen for 
immunohistochemical characterization after a period of 14 days.  The cell transplantations 
yielded robust engraftments and dystrophin (DYS) expressing myofibers (Figure 20a,b).  The 
extent of myofiber formation was quantified using the regeneration index (RI) metric, a measure 
of DYS+ myofibers in cryosectioned mdx muscle per 105 cells injected, as described 
previously52.  Significantly greater RIs were observed in the muscles injected with ALDHhi 
myoblasts compared to ALDHlo myoblasts, suggesting that the survival, proliferation, and/or 
differentiation capacity of ALDHhi myoblasts was greater in vivo than ALDHlo myoblasts, which 
correlated with the results obtained in vitro. 
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Figure 20.  Skeletal muscle regeneration capacity of ALDH sorted myoblasts 
(a)  ALDH sorted myoblasts (2 x 105 cells) were injected intramuscularly into the gastrocnemius of mdx 
mice and analyzed after 14days.  An increased number and density of dystrophin positive myofibers were 
observed in mice injected with ALDHhi cells compared to those injected with ALDHlo myoblasts.  
Dystrophin (DYS) positive myofibers (stained in red) indicate transplanted ALDHlo cell myofiber 
generation or fusion with a host myofiber.  Nuclei are DAPI (blue) stained.  Fluorescent green Fluosphere 
beads localize the area of initial injection.  (b) Significantly increased regeneration index was observed in 
ALDHhi transplanted mice compared to those injected with ALDHlo and unsorted cells. (* indicates p < 
0.05). 
 
 To understand the increased stress resistance capacity of the ALDHhi myoblasts, we 
examined two major intracellular antioxidants, reduced GSH and SOD.  Significantly increased 
concentrations of GSH and increased activity of SOD was observed in ALDHhi myoblasts 
compared ALDHlo myoblasts using spectrophotometric assays (Figure 21). The association of 
elevated ALDH activity with elevated intracellular anti-oxidant levels suggests a mechanism by 
which these cells are able to withstand oxidative and inflammatory stress conditions. 
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Figure 21.  Intracellular anti-oxidant (GSH and SOD) levels of ALDH sorted myoblasts 
(a-b) Measurements of intracellular antioxidant levels in terms of glutathione (GSH) and superoxide 
dismutase (SOD) demonstrated statistically significant elevation of both anti-oxidants in ALDHhi 
myoblasts compared to ALDHlo myoblasts.  (* indicates p < 0.05). 
 
3.5.5 Mechanism of increased stress resistance in ALDHhi murine myoblasts 
To elucidate the role of intracellular anti-oxidant levels in the stress resistance capacity of ALDH 
sorted myoblasts, we altered the cells anti-oxidant levels prior to oxidative stress challenge.  
ALDHlo myoblasts were treated with a mitochondrial targeted anti-oxidant, XJB-5-131 (XJB) 
prior to exposure to hydrogen peroxide to determine whether the proliferation rate could be 
elevated to that of ALDHhi cells237.  On the other hand ALDHhi myoblasts were treated with a 
GSH sequestrator, diethyl maleate (DEM) prior to oxidative stress exposure in order to alter their 
intracellular anti-oxidant levels275. 
Alteration of the anti-oxidant levels of these ALDH sub-populations had a significant 
impact on their proliferation capacities in oxidative stress.  Figure 22a depicts the proliferation 
advantage of ALDHhi myoblasts compared to ALDHlo myoblast as observed previously.  By 
increasing the anti-oxidant levels of ALDHlo cells with XJB prior to oxidative stress exposure 
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the proliferation rate was significantly increased, to a level statistically equivalent to that 
observed in the ALDHhi myoblasts (Figure 22b).  On the other hand, when the anti-oxidant levels 
of ALDHhi myoblasts were decreased by treatment with DEM, their proliferation rate was 
significantly decreased to that observed in the ALDHlo myoblasts (Figure 22c).  This result 
suggests that the differences in stress resistance between the ALDHhi and ALDHlo myoblasts is 
conferred by differences in their oxidative stress handling capacities, which can be easily modified 
using anti-oxidant and pro-oxidant treatment. 
 
Figure 22.  Anti-oxidant and pro-oxidant treatment of ALDH sorted myoblasts to elucidate the role of 
intracellular anti-oxidant levels on oxidative stress resistance 
(a)  As shown in Figure 18 ALDHhi early preplate myoblasts have greater proliferative capacity in oxidative stress 
than ALDHlo myoblasts. (* indicates p < 0.05).  (b)  However this proliferative advantage of ALDHhi myoblasts was 
lost when these cells are pre-treated (Tx) with the GSH inhibitor, diethyl maleate (DEM).   (c)  When ALDHlo 
myoblasts were treated with the anti-oxidant, XJB-5-131, their proliferative capacity was improved to a level 
observed in ALDHhi myoblasts. 
  
The next question that we addressed was whether ALDH was directly participating in the 
oxidative stress resistance of ALDHhi myoblasts.  Only in the ocular lens and cornea has ALDH 
been directly implicated in the mitigation of oxidative stress276; however it should be noted that 
in the course of its primary reaction of oxidation of aldehydes to carboxylic acids, it reduces the 
cofactor NADP+ to NADPH.  Given the role of NADPH in GSH recycling via glutathione 
reductase, we hypothesized that ALDH may in fact participate directly in the elevated anti-stress 
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resistance of ALDHhi myoblasts 199.  However, when we treated the ALDHhi cells with DEAB 
(200µM), a potent inhibitor of ALDH, for 24hrs prior and during oxidative stress exposure we 
observed no difference in the proliferative capacity of ALDHhi cells in oxidative stress 
conditions (Figure 23b,c).  This result suggests that ALDH is not directly participating in the 
increased anti-oxidant capacity of ALDHhi myoblasts and that elevated ALDH activity may 
simply be a marker for myoblasts with elevated stress resistance capacity.  Similarly no impact 
of DEAB on the proliferation capacity of ALDHlo myoblasts (Figure 23d,e). 
 
 
Figure 23.  ALDH inhibition by DEAB does not alter stress resistance behavior of ALDH sorted myoblasts 
DEAB is a strong inhibitor of ALDH activity, however it did not alter the proliferative behavior of ALDH sorted 
myoblasts in proliferation media treated with H2O2 (250 µM).  (a)  Similar to the result observed in Figure 18, an 
increased rate of ALDHhi myoblast proliferation in oxidative stress compared to ALDHlo myoblasts was observed.  
(b)  DEAB inhibition of ALDH did not inhibit proliferation of ALDHhi myoblasts to that of ALDHlo myoblasts.  (c-
d)  Nor did DEAB inhibition of ALDH alter the proliferative behavior of ALDHhi or ALDHlo myoblasts. 
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3.5.6 Chondrogenic and osteogenic differentiation of ALDH sorted myoblasts 
Two clear features of myoblasts with elevated ALDH expression have emerged from the 
experiments discussed thus far: increased stress resistance capacity and myogenic differentiation 
capacity.  In working with these cells, we questioned whether these two attributes were linked.  
That is, these cells may have increased myogenic differentiation capacities because of their 
increased stress resistance. One may consider the low serum conditions of myogenic 
differentiation medium as another kind of stress condition, which to has been shown to induce 
apoptosis in those cells that fail to differentiate into MHC+ cells253,254. The cell’s capacity to 
survive and function normally in adverse or altered media conditions is a necessary precondition 
to establish differentiation potential.  We therefore hypothesized that elevated ALDH expression 
and stress resistance capacity could also favor osteogenic and chondrogenic differentiation in 
vitro, given the dramatic alteration in media conditions. 
We studied the osteogenic and chondrogenic differentiation of ALDH sorted myoblasts 
and found that, indeed, ALDHhi myoblasts demonstrate a greater capacity to undergo 
chondrogenic and osteogenic differentiation in vitro as illustrated in Figure 24.  When 
chondrogenic differentiation was induced in ALDH sorted myoblasts, rapid pellet formation was 
observed in ALDHhi myoblasts (24hrs) with robust production glycosaminoglycans (GAGs).  
This behavior mirrors that of the unsorted myoblasts (Figure 24a) suggesting that the 
chondrogenic potential of unsorted myoblasts may be conferred by the ALDHhi myoblasts.  
However ALDHlo myoblasts showed poor proliferation in the chondrogenic media and formed 
smaller, less dense pellets that required 2-3d to coalesce.  Even after 21d of culture, increased 
cell density and glycosaminoglycans (GAG) formation was observed via Alcian blue staining in 
ALDHhi myoblasts compared to ALDHlo myoblasts (Figure 24a-c).  Osteogenic differentiation of 
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murine myoblasts was induced via bone morphogenic protein-4 (BMP-4) stimulation.  The 
unsorted myoblast population increased their alkaline phosphatase production in response to 
BMP stimulation (Figure 24d), which was also observed in ALDHhi myoblasts (Figure 24e).  
However a poor alkaline phosphatase response was observed in ALDHlo myoblasts.   As was 
observed in chondrogenic media conditions, the osteogenic differentiation potential of unsorted 
myoblasts appears to be conferred by the ALDHhi myoblasts (Figure 24d-f). 
While the differences in osteogenic differentiation in ALDH sorted myoblasts may either 
be attributed to increased osteogenic capacity or increased media stress resistance, the case of 
chondrogenic differentiation capacities implicates another mechanism.  It seems clear that 
ALDHlo myoblasts experienced some form of growth retardation in chondrogenic media 
compared to ALDHhi myoblasts to the extent that ALDHlo myoblasts did not form a condensed 
pellet.  Therefore the inability of ALDHlo myoblasts to survive and proliferate in chondrogenic 
media impaired their capacity for chondrogenic differentiation, as measured by pellet size and 
amount of GAG production.  Therefore, we believe that the increased survival and proliferation 
potential of ALDHhi myoblasts may also improve the differentiation yield in not only myogenic 
differentiation but also chondrogenic and osteogenic differentiation. 
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Figure 24.  Chondrogenic and osteogenic differentiation capacity of ALDH sorted myoblasts in vitro 
(a-c)  Chondrogenic differentiation potential of ALDHhi myoblasts was shown to be greater than ALDHlo 
myoblasts in vitro in terms of pellet formation after 21d and glycosaminoglycan (GAG, stained in violet) 
production.  (d-f) Osteogenic differentiation was induced in vitro by BMP-4 stimulation.  Alkaline 
phosphatase (ALP, shown in blue) levels were significantly increased in ALDHhi myoblasts compared to 
ALDHlo myoblasts after a period of 4d. 
 
 
3.5.7 Isolation and stress resistance of ALDH sorted MDSCs 
Given the heterogeneity of ALDH activity and stress resistance in myoblasts, we hypothesized 
that perhaps similar heterogeneity may exist within the MDSC populations as well.  We have 
previously observed increased stress resistance in MDSCs compared to myoblasts, however, we 
reasoned that there may exist an ALDHhi subpopulation of MDSCs that is responsible for this 
enhanced stress resistance.  ALDHhi and ALDHlo subpopulations of murine MDSCs were 
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isolated by FACS in the same fashion as murine myoblasts.  Representative FACS isolation of 
ALDHhi and ALDHlo MDSCs is illustrated in Figure 25a. 
 In contrast to myoblasts, MDSCs did not display a high degree of heterogeneity in ALDH 
expression (Figure 25) or in stress resistance behavior when sorted into ALDHhi and ALDHlo 
subpopulations.  This is not surprising given the already elevated stress resistance of MDSCs 
compared to myoblasts shown previously52.  Isolation of ALDHhi and ALDHlo MDSCs yielded a 




Figure 25.  FACS isolation and proliferation capacity of ALDH sorted MDSCs in oxidative and inflammatory 
stress conditions 
(a) In the same isolation protocol illustrated in Figure 15, ALDHhi SCClo (high ALDH activity, low side scatter) 
cells were isolated from MDSCs using DEAB, an ALDH inhibitor, as a control.  (b-c)   No difference in 
proliferative capacity of ALDH sorted MDSCs were observed in either oxidative (H2O2, 250µM) or inflammatory 
stress (TNF-α, 2.5ng/ml)  
 
Although a perceptible trend of increased myogenic differentiation index was observed in 
ALDHhi MDSCs when compared to ALDHlo MDSCs, these trends were not statistically 
significant except at one very high oxidative stress dose (H2O2, 500µM) and one intermediate 
inflammatory stress does (TNF-α, 1ng/ml). 
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Figure 26.  Myogenic differentiation of ALDH sorted MDSCs in oxidative and inflammatory stress 
(a)  ALDH sorted MDSCs underwent myogenic differentiation in oxidative stress (H2O2, 250µM) by 
expressing myosin heavy chain (MHC) and fusing into MHC+ clusters rather than fusiform myotubes.  (b)  
No significant differences in myogenic differentiation indices (MDI) was observed in ALDHhi MDSCs  
compared to ALDHlo MDSCs except at very high oxidative stress (H2O2, 500µM) and at one intermediate 
inflammatory stress level (TNF-α, 1ng/ml) ((indicated by *). 
When injected intramuscularly into the mdx mouse gastrocnemius, both ALDHlo and ALDHhi 
MDSC subpopulations demonstrated robust engraftment; however, no significant difference in the RIs of 
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Figure 27.  Skeletal muscle regeneration capacity of ALDH sorted MDSCs 
(a)  ALDH sorted MDSCs (2 x 105 cells) were injected intramuscularly into the gastrocnemius of mdx 
mice and analyzed after 14days.  Robust engraftment of both MDSC sub-populations was observed.  
Dystrophin (DYS) positive myofibers (stained in red) indicate transplanted ALDHlo cell myofiber 
generation or fusion with a host myofiber.  Nuclei are DAPI (blue) stained.  Fluorescent green Fluosphere 
beads are observed to localize the area of initial injection.  (b) No statistically significant differences in 
regeneration index were observed in ALDHhi transplanted mice compared to those injected with ALDHlo 
and unsorted cells.   
 
Not surprisingly, there were no significant differences observed in the GSH or SOD levels between the 
two ALDH sorted sub-populations of MDSCs (Figure 28).  This result suggested that no elevation in 
stress resistance or regenerative capacity could be achieved by isolating an ALDHhi subpopulation from 
MDSCs. 
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Figure 28.  Intracellular antioxidant levels (GSH and SOD) of ALDH sorted MDSCs 
(a-b) Measurements of intracellular antioxidant levels in terms of glutathione (GSH) or superoxide 
dismutase (SOD) levels indicated no statistically significant differences between ALDHlo and ALDHhi 
MDSCs. 
 
Although no statistically significant difference in myogenic differentiation capacity was 
observed in ALDHlo and ALDHhi MDSCs, chondrogenic and osteogenic differentiation capacity 
was examined as well. Chondrogenic differentiation of ALDH sorted myoblasts was induced in 
chondrogenic media and in pellets.  Mouse MDSC chondrogenesis was observed in monolayer 
form and stained for collagen type II after 4 days (Figure 29a-c).  Although increased cell 
proliferation was observed in ALDHhi MDSCs and unsorted MDSCs compared to ALDHlo 
MDSCs, no differences in collagen II positivity per cell was observed.  Osteogenic 
differentiation potential of MDSC was studied in plated cells under bone morphogenic protein-4 
(BMP-4) stimulation. Increased alkaline phosphatase expression was observed in ALDHhi and 
unsorted MDSCs compared to ALDHlo MDSC (Figure 29d-f). 
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Figure 29.  Osteogenic and chondrogenic capacity of ALDH sorted MDSCs 
(a-c)  Osteogenic differentiation of ALDH sorted MDSCs was induced in vitro by BMP-4 stimulation.  
Alkaline phosphatase (ALP, shown in blue) levels were increased in ALDHhi MDSCs compared to 
ALDHlo MDSCs.  (d-f)  However no observable differences in the chondrogenic differentiation potential 
of ALDHhi MDSCs could be shown by collagen II immunostaining (seen in red). 
3.6 DISCUSSION 
Our recent research on the muscle regenerative capacity of various myogenic progenitors 
suggests that stress resistance is predictive of muscle regeneration capacity52,74,130.  Following 
transplantation, precipitous and acute cell loss is observed which has been attributed to 
inflammation, anoikis, and ischemia200.  We have shown that by modulating the anti-oxidant 
levels of MDSCs we can alter its skeletal muscle regenerative capacity both in cardiac and 
skeletal muscle52,130. Similar studies using anti-oxidant and anti-inflammatory treatments such as 
SOD-mimetics162, anti-inflammatories45, such as anti-TNF-α and anti-neutrophil antibodies277 
further demonstrate the importance of stress resistance in the context of cell survival in cell 
therapy. While numerous immunosuppressive and anti-oxidant modalities have been identified to 
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increase cell survival following transplantation, cellular candidates for transplantation may also 
be screened for or isolated by their inherent survival capabilities200,216.  It is this approach that 
has motivated the present study as well as other ongoing studies in our group. 
The present study was motivated by an interest in isolating a myogenic progenitor 
population with elevated stress resistance capacity.  We observed an enrichment of ALDHhi cells 
in late preplate cells, a population with a known elevated oxidative stress resistance, which led us 
to hypothesize that ALDH may be a marker for elevated stress resistance.  As discussed 
previously, this hypothesis was supported by evidence of enhanced stress resistance in ALDHhi 
cells found in other cell lineages.  Following transplantation, cell competence in terms of 
survival, proliferation, and myogenic differentiation largely determines efficacy in skeletal 
muscle regeneration.  The conditions that donor cells encounter upon transplantation are 
deleterious to survival and tissue specific differentiation, as the host inflammatory process is 
initiated within minutes, exposing the cells to the oxidative stress from cytotoxic radicals and 
pro-inflammatory cytokines44. 
 The improved proliferative capacity of ALDHhi myoblasts and hMDCs over that of 
ALDHlo myoblasts and hMDCs in the presence of H2O2 and TNF-α in vitro suggests that the 
ALDHhi cells will have an increased proliferative capacity under conditions of inflammation in 
vivo.  Similarly, an increased differentiation capacity in conditions of oxidative and 
inflammatory stress is likely to translate to an improvement in the differentiation capacity when 
the cells are exposed to post-transplantation inflammation.  Indeed we observed improved 
muscle regeneration in muscles injected with ALDHhi myoblasts compared to ALDHlo 
myoblasts, which appears to be a function of improved survival, proliferation, and myogenic 
differentiation. 
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 A possible mechanism for this improved regeneration capacity of ALDHhi myogenic cells 
may be elevated intracellular levels of antioxidants such as GSH and SOD, an observation that 
was also made previously in MDSCs52.  This hypothesis is supported by the finding that 
increasing the anti-oxidant levels of ALDHlo myoblasts by treating them with XJB improved 
their proliferative capacity to a similar level observed in the ALDHhi myoblasts.  Furthermore, 
decreasing the GSH anti-oxidant levels of ALDHhi cells by treating them with DEM, inhibited 
their proliferative capacity to a similar level observed in the ALDHlo myoblasts.   
 While cytosolic ALDH (ALDH1A1) may be considered a detoxifying enzyme and an 
antioxidant in ocular tissues such the cornea and lens, it does not appear to actively participate in 
the antioxidant capacity of the cells studied here.  ALDH eliminates aldehydes by an oxidation 
reaction that simultaneously reduces NADP+ to NADPH, a cofactor for glutathione reductase 
recycling of GSH.  However, ALDH does not appear to functionally mediate stress resistance in 
the cells isolated in this study, given that DEAB inhibition did not affect the stress resistance 
capacity of the ALDHhi myoblasts. 
 That a similar improvement in stress resistance was not observed in ALDHhi MDSCs 
suggests that MDSCs already have an elevated stress resistance capacity that is not further 
enhanced by ALDH sorting.  Ongoing studies of ALDH sorting of freshly digested muscle may 
further elucidate the relationship between MDSCs and ALDHhi muscle derived cells. 
 Osteogenic and chondrogenic lineage potential was shown to be substantially greater in 
ALDHhi myoblasts than in ALDHlo myoblasts; however, we posit that this result may simply be 
explained by an increased capacity of these cells to survive the chondrogenic and osteogenic 
media conditions, given the poor proliferation of ALDHlo myoblasts in chondrogenic media and 
inability to form a dense pellet.  ALDHhi MDSCs underwent osteogenic differentiation at greater 
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rate than ALDHlo MDSCs however no significant difference was observed in their chondrogenic 
differentiation capacity.  Further experiments may be required to understand this observation, 
particularly given that no obvious difference in stress resistance was observed between these two 
MDSC populations. 
While numerous myogenic cells have been identified for muscle cell therapies, 
identification of definitive or even desirable markers for myogenic progenitor isolation remains 
elusive45.  In our experience, a common feature of myogenic progenitors with high regeneration 
potential lies in their increased resistance to oxidative and inflammatory stress52,74.  That is, these 
cells not only resist apoptosis, but they maintain increased rates of proliferation and myogenic 
differentiation capacity.  In the current study, we isolated ALDHhi and ALDHlo subpopulations 
of cultured murine myoblasts and MDSCs in addition to human muscle derived cells.  The utility 
of isolating myogenic cells with elevated ALDH expression is two-fold.  Myogenic progenitors 
may be rapidly isolated from heterogeneous populations of muscle derived cells using a simple 
intracellular dye, Aldeflour.  In addition, ALDH may be used as a marker to identify cells with 
an increased survival capacity when exposed to oxidative and inflammatory stress.  Our studies 
suggest that increased survival and stress resistance is a primary but not often studied 
determinant of effective cell therapy.  In our continued work, we seek a greater understanding of 
the mechanisms responsible for increased regeneration capacity and an understanding of what 
allows some progenitors greater survival abilities in the presence of oxidative and pro-
inflammatory environments.  The data presented in this study suggests that ALDH can be used as 
a marker to identify progenitors that are not only myogenic but have elevated oxidative and 
inflammatory stress resistance. 
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4.0  SPECIFIC AIM 3: ALDH ACTIVITY AS A MARKER FOR MYOGENIC 
CAPACITY AND STRESS RESISTANCE IN HUMAN MUSCLE DERIVED CELLS 
4.1 BACKGROUND 
4.1.1 Aldehyde dehydrogenase as a marker for early progenitor status in human cells 
Enhanced ALDH activity has been observed in primitive progenitors of hematopeitic180,181, 
mesenchymal182, endothelial183, and neural184,185 lineages.   ALDH expression is associated with 
retinoic acid metabolism, a mediator of stem cell maintenance and differentiation, and confers 
oxazaphosphorine chemotherapy resistance in metastasis competent carcinoma stem 
cells151,187,188.  Cells with elevated ALDH levels become fluorescent when exposed to boron-
dipyrromethene (BODIPY) labeled amino acetaldehyde (BAAA) and can be isolated using 
fluorescence activated cell sorting (FACS).  BAAA diffuses freely into the cytoplasm and is 
converted to BIODIPY-aminoacetate by ALDH, specifically ALDH1A1189. 
Vauchez et al. recently identified an ALDH+ myogenic progenitor population in skeletal 
muscle, which occupies an endomysial niche similar to that of the satellite cell186.  This group 
isolated ALDH+ cells from human muscle biopsies and demonstrated their myogenic potential 
both in vitro and in vivo.  Furthermore, they demonstrated that the ALDH+CD34- (and CD56+) 
cells in this population were responsible for this myogenic potential.  Another important result 
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from this paper was the robust engraftment of these ALDH+CD34- cells in the skeletal muscle of 
SCID mice.  They estimated that the engrafted cell population at 4 weeks post-transplantation 
was roughly 2-5 times the number of cells that were injected.  These results are summarized in 
Figure 30 below.  Although these results were very similar to our study on ALDHhi muscle 
derived cells, our study focuses on the potential of these cells from myogenic therapy, 
particularly on the cells ability to withstand oxidative and inflammatory stress, and whether this 
sub-population of cells indeed demonstrate elevated regeneration capacity over the ALDHlo 
subpopulation.  
 
Figure 30.  ALDH+ myogenic progenitors isolated from human skeletal muscle 
(a) Vauchez isolated ALDH+ (SMALD+ stands for Skeletal Muscle ALdehyde Dehydrogenase) cells from 
human skeletal muscle and demonstrated myogenic potential in vitro of ALDH+CD34-.  (b)  When these 
sub-populations were injected intramuscularly in to SCID mice, ALDH+CD34- not only fused with 
existing myofibers but also took up residence in an endomysial position (indicated by arrows) similar to 
that occupied by the satellite cell.   However, ALDH+CD34+ cells demonstrated poor engraftment and no 
myofiber fusion. 
 
The co-authors identified the prevalence of several key surface markers of the ALDH and 
CD34 sorted skeletal muscle derive cells listed in Table 1186.    Much of the ALDH sorting 
literature is devoted to isolating hematopoietic stem cells, which commonly uses the CD34 
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surface marker for identification of primitive hematopoietic cells.  The co-authors sought to 
determine whether this is also an important marker for muscle progenitors as well.  Therefore 
they isolated four subpopulations of dissociated muscle biopsy derived cells based on ALDH and 
CD34.  A few important findings were described here.  The majority of the muscle derived cells 
were SMALD−CD34−, which also coincided with the majority of the CD56 expressing cells.   
Each subpopulation was clearly heterogeneous in terms of lineage commitment because typically 
only a minority of cells from each sub-population were positive for the markers analyzed (CD31, 
CD44, CD45, CD56, CD90, CD105, and CD104b).  The SMALD+CD34+ population was 
negative for CD45, CD56, CD105, and largely for CD31 as well.  Whereas the SMALD+CD34− 
population expressed a larger proportion of CD44+ cells than the SMALD+CD34+ cells.  It 
should be noted that both SMALD+ sub-populations expressed no CD56+ unlike the double 
negative population, suggesting that the SMALD+ may not have made a myogenic lineage 
commitment at the time of isolation. 
 
Table 1.  Human ALDH sorted skeletal muscle cells surface marker analysis186 
 
 
We have isolated similar populations of human ALDHhi myogenic progenitors from 
unfractionated human muscle cells. As in our murine myogenic progenitor study, we 
hypothesized that increased ALDH activity may identify myogenic progenitors with increased 
oxidative and inflammatory stress resistance.  As discussed previously, we believe this increased 
stress resistance may confer an increased engraftment and muscle regeneration capacity over 
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ALDHlo and unsorted muscle derived populations.  Like Vauchez et al, we observed survival of 
these ALDHhi cells in myogenic culture conditions and therefore sought to isolate ALDHhi cells 
from cultured myogenic progenitors. 
4.2 RATIONALE 
While Vauchez et al. observed increased myogenic capacity in an CD34+ALDHhi subpopulation 
of muscle derived cells, the authors did not address why this might be the case or whether ALDH 
alone is a marker for increased myogenic potential186.  We seek to determine the whether anti-
oxidant capacity or stress resistance plays a role in the myogenic capacity of human ALDHhi 
cells.  We have isolated ALDHhi and ALDHlo populations from human and murine muscle 
derived cells (hMDCs and mMDCs).  We hypothesized that increased ALDH activity may 
identify myogenic progenitors with increased stress resistance thus conferring an increased 
engraftment and muscle regeneration capacity in vivo over the ALDHlo and unsorted MDC 
populations.  We sought to identify their intracellular anti-oxidant levels of ALDHhi and ALDHlo 
in terms of GSH and SOD.  This tolerance will also be evaluated in terms of intracellular ROS 
accumulation. 
4.3 EXPERIMENTAL DESIGN 
ALDHhi and ALDHlo populations of hMDCs were isolated using fluorescence activated cell 
sorting (FACS).  The proliferation and differentiation potential of these populations in the 
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presence of oxidative (H2O2) and inflammatory stress (TNF-α) were evaluated in vitro and 
compared to the unsorted hDMC population.  The anti-oxidant levels in terms of glutathione and 
superoxide dismutase were evaluated and compared to the unsorted populated.  Reactive oxygen 
species accumulation during oxidative challenge (H2O2) was measured as well, as depicted in the 
schematic in Figure 31 below: 
 
Figure 31.  Experimental schematic to examine the stress resistance capacity of ALDH sorted hMDCs 
ALDHlo and ALDHhi subpopulations of muscle derived cells (MDCs), human in this case, was isolated by 
fluorescent activated cells sorting (FACS).  Proliferative and myogenic differentiation capacity was quantified in 
conditions of oxidative (H2O2) and inflammatory stress (TNF-α, not shown in schematic).  Intracellular anti-oxidant 
levels, specifically reduced glutathione (GSH) and super-oxide dismutase (SOD) was assessed in each ALDH sorted 
subpopulation of hMDCs.  The oxidative stress handling capacity of hMDCs was assessed during oxidative stress 
(H2O2) challenge by measuring changes in the intracellular reactive oxygen species (ROS) concentration. 
 
The skeletal muscle regeneration capacity of the ALDHhi and ALDHlo subpopulations 
was evaluated in the gastrocnemius of an mdx mouse model.  To conform to relevant in vivo 
studies of human myoendothelial cells74, ALDH sorted hMDCs were transplanted into male 
mdx/SCID mice, as seen in the schematic in Figure 32 below: 
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Figure 32.  Experimental schematic to examine the muscle regenerative capacity of ALDH sorted hMDCs 
ALDHlo and ALDHhi hMDCs was injected directly into the gastrocnemius muscles of female mdx mice aged 6-8 
weeks.  The regeneration index was quantified via histological evaluation of the rate of dystrophin expression of 
cryosectioned muscle 14 days post-injection. 
4.4 METHODS 
4.4.1 Human muscle cell isolation 
Skeletal muscle biopsies obtained during surgery, were placed on ice in Hanks’ balanced salt 
solution (HBSS), finely minced, and digested for 60 min at 37 °C with type-I and type-IV 
collagenases (100 mg/ml) and dispase (1.2 mg/ml).  Digested tissue was pelleted and 
resuspended in DMEM supplemented with 10% fetal bovine serum (FBS) and 1% 
penicillin/streptomycin (P/S), triturated and then passed through a 40-mm filter to obtain a single 
cell suspension.  Cells were either sorted by FACS or placed in collagen coated flasks in a 
proliferation media and cultured at 37°C and 5% CO2. 
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4.4.2 Flow cytometric analysis and sorting by ALDH activity 
Cultured human muscle derived cells were trypsinized, washed in cold PBS, and counted using a 
hemocytometer.  To analyze and sort hDMCs on the basis of ALDH activity, cells (n=106) of 
each population were resuspended in ALDEFLUOR buffer and incubated at 37°C with BAAA 
according to manufacturer’s instructions (Aldagen Inc, Durham, NC).  Cells were washed in 
ALDEFLUOR buffer and maintained in 4°C.  ALDH activity was assessed using the FL1 
channel of a BD FACSAria Cell Sorting System and FACSDiva software.  Collected cells were 
gated on their ALDH activity levels, as determined by a DEAB inhibited control sample, and 
low side scatter (SCClo). 
4.4.3 In vitro proliferation capacity 
Time-lapse live cell microscopy were employed to monitor the rate of proliferation under 
conditions of oxidative and inflammatory stress246,247.  Sorted hMDCs were plated in collagen-
coated 24-well plates at an initial density of 1000 cells/cm2 in proliferation medium and 
incubated under normal conditions for 24hrs.  Stress conditions of oxidative (250µM, H2O2) and 
inflammatory stress (2.5ng/ml, TNF-α) in PM were initiated 30min prior to placing the plate on 
live cell imaging incubator.  Cell proliferation was quantified at 30min intervals in three 10x 
microscope fields over a period 48 hrs. 
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4.4.4 In vitro muscle differentiation capacity 
Cells were plated at an initial density of 1000 cells/cm2 in 24-well plates and allowed to 
proliferate for 2d or until near confluence in proliferation medium.  Proliferation media were 
exchanged for differentiation media treated to simulate oxidative stress (0µM, 100µM, 250µM, 
and 500µM, H2O2) and inflammatory stress (1ng/ml, 2.5ng/ml, and 5ng/ml, TNF-α) and 
exchanged daily to maintain initial stress levels52.  Cells were allowed to differentiate and fuse 
for 4d then fixed with cold methanol (-20°C).  Differentiation of myogenic cells into myosin 
heavy chain (fast) expressing myotubes was quantified using the MDI metric described 
previously. 
4.4.5 Intracellular antioxidant capacity 
The antioxidant capacity was measured in terms of the major intracellular anti-oxidant molecules 
GSH and SOD activity as well as intracellular reactive oxygen species accumulation during 
H2O2 challenge.  Levels of GSH were measured colorimetrically (Calbiochem, 354102) using a 
spectrophotometer (TECAN Infinite M200).  Total activity of SOD was measured using a 
colorimetric assay (Chemicon, Temecula, CA; APT290) from cell lysates according to the 
manufacturer’s directions.  Intracellular ROS levels were measured fluorometrically using 
carboxy-H2DCFDA.  Briefly, cells were plated at an initial density of 1000 cells/cm2 in 24 well 
plates and incubated for 24h.  The cells were loaded with 5 mM carboxy-H2DCFDA for 30 min 
in proliferation media, washed, and exposed to 250 µM H2O2 in proliferation medium.  Cell 
fluorescence intensity was measured at 30 min intervals for 4 hrs using a fluorometric plate 
reader.  
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4.4.6 Skeletal muscle regeneration capacity 
Sorted human muscle cells were injected into the gastrocnemius muscles (n=4) of male 
mdx/SCID mice (aged 6–8 weeks), using the protocol described previously.  This experiment 
will require 16 mice per cell type (experimental groups include unsorted cells, ALDHhi, ALDHlo, 
and PBS control groups). 
4.4.7 Statistical Analysis 
 Data are expressed as a mean with its standard deviation.  Direct comparisons between two cell 
populations were made using an unpaired, two-tailed Student’s t test, where statistical 
significance was determined at a level p < 0.05.  Comparisons of multiple groups were 
completed using one-way ANOVA followed by Tukey post-hoc comparisons. 
4.5 RESULTS 
4.5.1 Stress resistance of ALDH sorted hMDCs 
Following FACS isolation of ALDHhi and ALDHlo subpopulations of hDMCs, oxidative (H2O2) 
and inflammatory (TNF-α) stress resistance during proliferation was quantified (Figure 33a and 
b). The proliferation rate of ALDHlo and ALDHhi subpopulations of hMDCs was quantified 
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using live cell imaging microscopy in conditions of oxidative (250µM, H2O2) and inflammatory 
(2.5ng/ml, TNF-α) stress.  A significant proliferation advantage of ALDHhi hMDCs was 
observed when normalized cell numbers are compared to ALDHlo hMDCs in both stress 
conditions. 
 
Figure 33.  FACS sorting of hMDCs on ALDH activity and ALDH sorted hMDC proliferation in oxidative 
and inflammatory stress 
(a)  A significantly increased rate of proliferation of ALDHhi hMDCs compared to ALDHlo hMDCs was 
observed in conditions of oxidative stress (H2O2, 250µM) (* indicates p < 0.05).  (b) Similarly ALDHhi 
hMDCs demonstrated elevated proliferative capacity in inflammatory stress conditions (TNF-α, 
2.5ng/ml). 
 
 The myogenic differentiation index (MDI), a measure the proportion of cells expressing of 
myosin heavy chain (MHC), of ALDHhi and ALDHlo hMDCs was quantified in conditions of 
oxidative (H2O2) and inflammatory (TNF-α) stress.  A significantly increased number of myosin 
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Figure 34.  Myogenic differentiation of ALDH sorted hMDCs in oxidative and inflammatory stress 
(a) ALDHlo and ALDHhi hDMCs underwent myogenic differentiation by fusing into MHC+ myotubes (red) under 
oxidative stress conditions (H2O2, 250 µM). Nuclei are stained with DAPI (blue).  (b) Significantly increased 
myogenic differentiation indices (MDI) were observed (p < 0.05) in ALDHhi hMDCs all concentrations of oxidative 
(H2O2) and inflammatory stress (TNF-α, 2.5/ml) when compared to ALDHlo hDMCs. 
4.5.2  Skeletal muscle regeneration capacity of ALDH sorted hMDCs 
ALDHhi and ALDHlo hMDCs injected intramuscularly in the gastrocnemius of mdx/SCID mice 
yielded robust engraftment and formation of dystrophin expressing myofibers (Figure 35).  The 
extent of myofiber formation was quantified using the regeneration index metric, a measure of 
DYS+ myofibers in a cryosectioned muscle per 105 cells injected, as described previously52.  
Significantly increased regeneration indices were observed in ALDHhi hMDCs compared to 
ALDHlo hMDCs. 
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Figure 35.  Skeletal muscle regeneration capacity of ALDH sorted hMDCs 
(a)  ALDH sorted hMDCs (2 x 105 cells) were injected intramuscularly into the gastrocnemius of mdx 
/SCID mice and analyzed after 14days.  An increased number and density of dystrophin positive 
myofibers were observed in mice injected with ALDHhi cells compared to those injected with ALDHlo 
myoblasts.  Dystrophin (DYS) positive myofibers (stained in red) indicate transplanted ALDHlo cell 
myofiber generation or fusion with a host myofiber.  Nuclei are DAPI (blue) stained.  Fluorescent green 
beads can be observed to localize the area of initial injection.  (c) Significantly increased regeneration 
index was observed in ALDHhi hDMC transplanted mice compared to those injected with ALDHlo and 
unsorted hMDCs. (* indicates p < 0.05). 
4.5.3 Stress resistance capacity of the ALDH sorted hMDCs 
To understand the increased stress resistance capacity of the ALDHhi hMDCs, we examined two 
major intracellular antioxidants, reduced glutathione GSH and SOD. Although a trend of 
increased GSH was observed in ALDHhi hMDCs compared to ALDHlo, this trend was not 
statistically significant, however a significant difference in intracellular SOD was observed 
(Figure 36). 
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Figure 36.  Intracellular anti-oxidant (GSH and SOD) levels of ALDH sorted hDMCs 
(a-b) Measurements of intracellular antioxidant levels in terms of glutathione (GSH) and superoxide 
dismutase (SOD) levels demonstrated a trend in increased GSH levels (not statistically significant) and 
significant elevation of SOD in ALDHhi hMDCs compared to ALDHlo myoblasts.  (* indicates p < 0.05). 
 
The accumulation of intracellular ROS during oxidative stress challenge was used as a 
metric of oxidative stress handling.  Intracellular ROS in ALDHhi hMDCs was significantly less 
than ALDHlo and unsorted hMDCs following hydrogen peroxide exposure (250µM, H2O2) at 
timepoints of 150min and beyond (Figure 37a).  Similarly, decreased ROS accumulation in 
ALDHhi hMDCs compared to ALDHlo was observed at increasing oxidative stress levels (25-
500µM H2O2) as illustrated in Figure 37b. 
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Figure 37.  Reactive oxygen species accumulation in hMDCs during oxidative stress 
Reactive oxygen species (ROS) accumulation in ALDH sorted hMDCs was measured during oxidative stress 
exposure (H2O2, 250µM).  (a) Decreased ROS accumulation as a function of time was observed in ALDHhi hMDCs 
when compared to ALDHlo hMDCs (# indicates p > 0.05) and unsorted hDMCs (* indicates p > 0.05). (b) Similar 
trends in ROS accumulation was observed at different oxidative stress conditions, where significantly less 
intracellular ROS levels were observed in ALDHhi hMDCs compared to both ALDHlo hMDCs and unsorted 
hMDCs. 
4.5.4 Osteogenic and chondrogenic differentiation potential of ALDH sorted hMDCs 
In order to determine whether ALDHhi hMDCs elevated differentiation capacity is limited to 
myogenic differentiation, we studied the osteogenic and chondrogenic differentiation of ALDH 
sorted hMDCs.  Osteogenic differentiation was induced in plated cells via BMP-4 stimulation.  
Because alkaline phosphatase was observed in all hMDCs even without prior BMP-4 
stimulation, osteocalcin was used as a marker of osteogenic differentiation.  However even in 
this case no observable difference in osteogenic differentiation capacity was observed in ALDH 
sorted hMDCs (Figure 38 a-c).  Chondrogenic differentiation of plated, ALDH sorted hMDCs 
was induced in chondrogenic media and qualified via collagen II immunohistochemical staining. 
No increased collagen II positivity was observed in ALDHhi compared to ALDHlo or unsorted 
hMDCs (Figure 38 d-f).  The high background observed in both of these stains has raised some 
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Figure 38.  Osteogenic and chondrogenic differentiation capacity if ALDH sorted hMDCs in vitro 
(a-c)  Osteogenic differentiation of ALDH sorted MDSCs was induced in vitro by BMP-4 stimulation.  
Osteocalcin (shown in red with blue DAPI nuclear counterstain) immunostaining did not indicate 
significant changes in osteogenic differentiation capacity in ALDH sorted hMDCs.  (d-f)  Similarly no 
observable differences in the chondrogenic differentiation potential of ALDHhi MDSCs could be shown 
by collagen II immunostaining (shown in red). 
4.6 DISCUSSION 
In the current study, we have isolated ALDHhi and ALDHlo subpopulations of cultured human 
muscle derived cells.  The isolation of ALDHhi progenitors yields a population of myogenic cells 
with enhanced oxidative and inflammatory stress resistance, which has been shown by our group 
to yield improved rates of engraftment and tissue regeneration.  This works adds to the growing 
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view of aldehyde dehydrogenase as a marker of early progenitor status among multiple lineages 
of human cells. 
The increased myogenic and stress resistance capacity of ALDHhi hMDCs also supports 
the earlier work of Vauchez et al; however, we posit that the increased stress resistance capacity 
of these cells plays a significant, and yet uncharacterized, role in the increased regenerative 
capacity of this sub-population of human muscle cells186.  While Vauchez et al. isolated 
myogenic progenitors from freshly dissociated human muscle on the basis of elevated ALDH 
activity and CD34-negativity, we isolated ALDHhi cells from un-fractionated human muscle 
derived cells previously expanded in culture or hMDCs. Primary human muscle cultures include 
a heterogeneous population of myoblasts, endothelial cells, fibroblasts and a multitude of other 
cell types; therefore, it is perhaps not surprising that we observed greater differences in oxidative 
stress resistance between ALDHhi and ALDHlo hMDCs given this heterogeneity.  Elevated 
ALDH activity can effectively be used to select for myogenic progenitors that can more 
effectively withstand the effects of oxidative and inflammatory stressors from a heterogeneous 
population of cultured hMDCs.  This result suggests that ALDH sorting of cultured human 
muscle derived cells may be as effective as sorting freshly digested muscle and selecting for 
ALDH positivity and CD34-negativity186. 
We observed that the behavior of ALDH sorted hMDCs was quite similar to that 
observed in murine myoblasts in terms of differences in stress resistance in vitro as well as 
regeneration indices in vivo.  A significant proliferation advantage of ALDHhi cells was 
observed in human hMDCs when exposed to either oxidative or inflammatory stress conditions.  
Similarly, a significantly increased MDI was observed for ALDHhi hMDCs at all oxidative and 
inflammatory stress doses, except for two lower doses of oxidative stress (25µM and 100µM, 
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H2O2).  In vivo, a significantly increased regeneration index was observed in ALDHhi hMDCs 
transplanted into mdx/SCID mice compared to those injected with ALDHlo and unsorted hMDCs.  
Although a trend of increased GSH was observed in ALDHhi hMDCs compared to ALDHlo, this 
trend was not significant, however a significant difference in intracellular SOD was observed. 
Following transplantation, cell competence in terms of survival, proliferation, and 
myogenic differentiation will determine efficacy in skeletal muscle regeneration.  The conditions 
the cell encounters upon injection may be hostile to these functions, as the host inflammatory 
process is initiated within minutes, which exposes the cells to hypoxia, numerous cytotoxic 
radicals, and pro-inflammatory cytokines.  The improved proliferative capacity of ALDHhi 
hMDCs over that of ALDHlo hMDCs in the presence of H2O2 and TNF-a suggests that the 
ALDHhi cells may have an increased proliferative capacity under conditions of neutrophil 
degranulation and other mediators of inflammation in the hours and days following 
transplantation. 
Indeed, a strong correlation of stress resistance in vitro and regeneration index in vivo 
was observed.  That is, ALDH sorting conferred a significant advantage in stress resistance in 
ALDHhi hMDCs compared to ALDHlo hMDCs which we believe is primarily responsible for  the 
significant improvement in regeneration index when injected into the gastrocnemius muscle of 
the SCID mouse. 
To determine if the enhanced proliferation and myogenic differentiation capacity of 
ALDHhi cells in conditions of stress may be the result of increased intracellular anti-oxidants, we 
measured elevated levels of GSH and SOD in the ALDHhi hMDC populations.  This result 
should be viewed in the context of studies of the redox signaling in the differentiation of 
primitive progenitors in which numerous cell lineages exhibit a trend of earlier progenitors 
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maintaining a more reduced intracellular environment than their more differentiated 
counterparts225.  Therefore this result not only suggests a mechanism for improved stress 
resistance but also lends evidence to elevated ALDH being a marker for more primitive cell 
status.   
Osteogenic and chondrogenic lineage potential has yet to be adequately characterized and 
is the focus of ongoing studies.  Our preliminary results to date do not suggest a difference in 
either lineage differentiation potential between ALDHlo and ALDHhi sub-populations of hMDCs.  
Ongoing work includes confirming the osteogenic and chondrogenic assay results shown in 
Figure 38.  Given the substantial difference in stress resistance capacity between ALDHlo and 
ALDHhi hMDCs, we hypothesize that we will observe increased osteogenic and chondrogenic 
potential of ALDHhi hMDCs as we observed in ALDH sorted murine myoblasts. 
Of the numerous myogenic cells that have been identified as candidates for myogenic cell 
therapies, it is our view that the common feature of myogenic progenitors with high regeneration 
potential lies in their increased resistance to oxidative and inflammatory stress45,52,74.  A vital 
criterion of myogenic cells is not only increased resistance to apoptosis, but increased rates of 
proliferation and myogenic differentiation capacity in conditions of stress.  In the current study, 
we isolated ALDHhi and ALDHlo subpopulations of cultured human muscle derived cells to 
study these properties.  Indeed, stress resistance appears to play an important role in the muscle 
regeneration capacity of ALDHhi hMDCs. 
Our studies suggest that increased survival and stress resistance is a major, but not often 
studied, determinant of effective cell therapy.  Although it has been known for many years that 
stem and progenitor cells display unique behavior such as self-renewing and long term 
proliferation in addition to multipotent differentiation, our results suggest that survival and 
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resistance to stress should be added to that list228. These results suggest that stem cell behavior 
likely represents a better determinant for stem cell therapy than the use of marker profiles that 
identify a given cell population. In our continued work, we seek a greater understanding of the 
mechanisms responsible for increased regeneration capacity and an understanding of what allows 
some progenitors greater survival abilities in the presence of oxidative and pro-inflammatory 
environments.  The data presented in this study suggests that ALDH can be used as a marker to 
identify progenitors that are not only myogenic but have elevated oxidative and inflammatory 
stress resistance. 
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5.0  DISSERTATION CONCLUSIONS 
Myogenic cell therapies are based on the rationale that muscle regeneration may be induced or 
augmented by increasing the native myogenic progenitor or stem cell reserve. However, 
engraftment efficiency in myogenic cell transplantation is impaired by a precipitous loss of cell 
viability following transplantation that is associated with the oxidative and inflammatory stress 
environment of inflammation.  This dissertation describes the isolation and characterization of 
murine and human populations of muscle derived cells that have an enhanced capacity to survive 
similar stress conditions induced by inflammation.   
 In the first specific aim of this dissertation (chapter 2), I examined the role stress resistance 
and survival during myogenic differentiation and muscle regeneration capacity of MDSCs and 
myoblasts derived from a modified preplate technique.  As an extension of the recent 
publications of Urish et al. and Drowley et al., I sought to clarify the role of intracellular 
antioxidant capacity of myogenic cells using a mitochondrial targeted reactive oxygen species 
scavenger, XJB-5-13152,262.   These studies suggest that survival during myogenic differentiation 
is an important is an important determinant of differentiation efficiency that should be 
considered when choosing a myogenic cell for cell therapeutic applications.  Furthermore, it is 
clear that XJB anti-oxidant pre-treatment of cells can improve cell survival and myogenic 
differentiation in normal and oxidative stress conditions.  While I did not observe statistically 
significant differences in the muscle regeneration capacity in treated and untreated myoblasts and 
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MDSCs, the trends of improved regeneration suggest that anti-oxidant pre-treatment can improve 
the engraftment and regeneration capacity of transplanted cells.  This reinforces the hypothesis 
that oxidative stress resistance is a primary determinant of muscle regeneration capacity. 
 In the second specific aim (Chapter 3), I describe the isolation ALDHhi and ALDHlo 
subpopulations of cultured murine myoblasts and MDSCs that in the case of ALDHhi myoblasts 
yielded improved regeneration capacity over their ALDHlo and unsorted myoblast counterparts. 
The utility of isolating myogenic cells with elevated ALDH expression is two-fold.  Myogenic 
progenitors may be rapidly isolated from heterogeneous populations of muscle derived cells 
using a simple intracellular dye, Aldeflour.  In addition, ALDH may be used as a marker to 
identify cells with an increased survival capacity in oxidative and inflammatory stress.  The 
improved proliferative capacity of ALDHhi myoblasts over that of ALDHlo myoblasts in the 
presence of H2O2 and TNF-α suggests that the ALDHhi cells are likely to have an increased 
proliferative capacity under conditions of inflammation that is seen in the hours and days 
following transplantation.  That a similar improvement in proliferative capacity was not observed 
in ALDH sorted MDSCs suggests one of two conclusions, either that the MDSCs already have 
an elevated stress resistance capacity that is not further enhanced by ALDH sorting or that 
MDSCs do not have a significant degree of heterogeneity in ALDH expression to effectively 
segregate ALDHlo and ALDHhi sub-populations.  Osteogenic and chondrogenic lineage potential 
was shown to be substantially greater in ALDHhi myoblasts than in ALDHlo myoblasts; however, 
we posit that this result may simply be explained by an increased capacity of these cells to 
survive the chondrogenic and osteogenic media conditions, given the poor proliferation of 
ALDHlo myoblasts in chondrogenic media and inability to form a dense pellet. 
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 In the third specific aim (chapter 4), I describe the isolation of ALDHhi and ALDHlo 
subpopulations of cultured human muscle derived cells (hMDCs).  Similar to murine myoblasts, 
ALDH hMDC sorting isolated a sub-population of ALDHhi hMDCs with improved regeneration 
capacity over their ALDHlo and unsorted myoblast counterparts.  This improved muscle 
regeneration capacity following cell transplantation into the skeletal muscle of mdx/SCID mice 
appears to be largely conferred by the increased oxidative and inflammatory stress resistance of 
ALDHhi hMDCs compared to ALDHlo and unsorted hMDCs.  Vauchez et al. describes a 
methodology of isolation ALDHhi cells from freshly dissociated skeletal muscle, however the 
study described in this dissertation suggests that cells with elevated stress resistance can also be 
isolated from cultured hMDCs.  This is significant because one may not need to subject these 
cells to the process of flow cytometry in addition to the exposure to the numerous digestive 
enzymes required for cell dissociation. 
 These studies were aimed at understanding the importance of survival and stress tolerance 
of myogenic cells in skeletal muscle cell therapy and how this tolerance modifies the efficacy of 
cell therapy.  Each of the three studies described here all suggest that stress tolerance is central to 
the efficacy of cell therapy.  Increased stress tolerance can be induced by treatment with an anti-
oxidant such as XJB-5-131 or cells with an inherent increase in stress tolerance can be isolated 
from a myogenic cell population on the basis of elevated ALDH activity. 
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6.0  OTHER RELATED PROJECTS 
The following chapter to devoted to projects that are either currently underway, constitute 
collaborative efforts in which I took part or projects that were initiated and discontinued. 
6.1 THE ROLE OF ANOIKIS RESISTANCE IN ISOLATING MDSCS 
6.1.1 Background 
Myogenic cell therapies have been limited by rapid and precipitous cell death within days of 
transplantation41,200,201.  Several mechanisms for this loss have been proposed including 
inflammatory and oxidative stress at the injection site18,41,127,202, hypoxia/ischemia203, and anoikis 
(apoptosis induced by loss of extracellular matrix (ECM) or adjacent cell contact)204,205,278.  
Anoikis is a poorly studied phenomenon in myoblast transfer therapy although has received 
increased attention relatively recently.   Bouchentouf et al. in 2007 observed myoblast survival in 
vivo could be enhanced several fold by the co-injection of fibronectin, the silencing of Bit1 and 
FADD expression, or by over expression of Bcl-2, all mediators of anoikis205.  Similarly, Silva-
Barbosa et al. found that similar increases in engraftment occurred with co-injection of 
laminins279.  However, anoikis specific signaling molecules have not be comprehensively 
elucidated given the overlap with other mechanisms of apoptosis280.  This dramatic improvement 
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in post-transplantation survival suggests that anoikis as a mechanism of cell loss and its 
mitigation to improve cell therapy deserves closer study. 
Work performed by our research group has shown that murine MDSCs, isolated by a 
modified preplate technique, display a high transplantation capacity in both skeletal and cardiac 
muscle42,43.  The MDSCs’ capacity for long-term proliferation and self-renewal, resistance to 
stress, ability to undergo multilineage differentiation, ability to induce neovascularization, and 
immune-privileged behavior—at least partially explains the high regenerative capacity of these 
cells in skeletal and cardiac muscles.  It has been shown that MDSCs survive transplantation at 
significantly greater rates than more differentiated myoblasts.  How much of this survival can be 
accounted by resistance to anoikis has not been evaluated.   
The preplate technique by which MDSCs are isolated suggest that these cells may have 
an enhanced ability to resist anoikis.  The preplate segregates cells that adhere rapidly to collagen 
coated flask surfaces from cells that are slow to adhere.  Cells that fail to adhere over a course of 
5 successive preplate passages are collected in a 6th preplate flask and are allowed to adhere over 
the course of several days.  It is these cells that are termed the muscle derived stem cells79.  It 
seems logical that these cells may perform better following transplantation in vivo partially 
because of their enhanced ability to resist anoikis however this ability has yet to be studied 
directly. 
We have isolated myogenic cells from skeletal muscle with elevated aldehyde 
dehydrogenase (ALDH).  ALDH expression is associated with retinoic acid metabolism, a 
mediator of stem cell maintenance and differentiation, and confers oxazaphosphorine 
chemotherapy resistance in metastasis competent carcinoma stem cells151,187,188.  Elevated 
expression of aldehyde dehydrogenase (ALDH) has been shown to be a marker of early 
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progenitor status in hematopeitic180,181, mesenchymal182, endothelial183, neural184,185, and recently 
skeletal muscle186 populations.  We have found that these ALDHhi sub-populations not only 
resist oxidative and inflammatory stress in vitro but have enhanced survival and engraftment in 
murine skeletal muscle281.  Anoikis resistance may play an important role in the improved 
transplantation characteristics of these cells, particularly in light of the increase in the use of 
ALDH to isolate and characterize tumorigenic and cancer stem cells capable of 
metastasis267,268,282,283. 
When cancer cells metastasize to distant sites in the body, they may do so by 
hematogenous or lymphatic spread which requires that they degrade and detach from the 
extracellular matrix of the primary tumor in a process similar to an epithelial to mesenchymal 
transition (EMT).  The cells must be able to survive this loss of cell contacts that would normally 
initiate anoikis, travel for some period of time before finding some hospitable tissue to re-initiate 
tumor growth284.  Frish and Screaton argue that anoikis resistance confers a selective advantage 
to metastasizing cells because it effectively increases the survival time after detachment284.  
Numerous authors have observed that ALDH is marker of poor prognosis given these cells 
propensity to survive radiation and chemotherapy (e.g. cyclophosphamide) and more importantly 
to metastasize, and recapitulate the tumor at a distant site.  These are properties that essentially 
define a cancer stem cell.  Is ALDH a marker for cells capable of shedding their extra-cellular 
matrix contacts?  Is it possible that ALDH has some essential function in blocking integrin 
mediated cell death?  There are questions that have yet to be addressed in the literature. 
As discussed previously, the use of ALDH to isolate stem cells is not limited to cancer.  
In fact, ALDH used to isolate hematopoietic stem cells from peripheral blood.   Clearly these 
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cells are capable of surviving being suspended in blood285-287.  These cells (particularly those that 
are CD45-negative) have been used to home to various tissues285. 
We are still quite a ways away from finding an effective cell therapy for skeletal muscle 
diseases such as DMD and traumatic injuries.  However, one of the most significant 
impediments, poor cell survival immediately following transplantation, may be mitigated by 
selecting for cells that have improved survival in the muscle transplantation environment. 
 
6.1.2 Experimental design 
We chose to explore the relationship between ALDH expression and anoikis resistance with two 
experiments.  The first entails measuring capacity ALDHhi and ALDHlo cells isolated from a 
murine skeletal muscle biopsy to survive under conditions of the preplate technique.  That is, we 
will examine the number of preplate cycles that ALDHhi and ALDHlo cells survive and 




Figure 39.  Experimental schematic to examine preplate survival of ALDH sorted murine muscle derived cells 
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The second experiment is designed to study the anoikis resistance of ALDH sorted 
muscle derived cells.  Cells dissociated from murine (female, WT 6J) skeletal muscle and placed 
immediately in media in a spinner bottle to prevent cell adhesion through settling or cell 
clustering (myosphere formation)288..  Spinner bottles of uncoated glass were used to maintain 
cells in culture for progressive durations (2d, 4d, and 6d) chosen to approximate the duration of 
the preplate technique. 
 
Figure 40.  Experimental schematic of to examine anoikis resistance cells for ALDH activity 
 
6.1.3 Results 
Freshly dissociated murine skeletal muscle cells were sorted into ALDHhi and ALDHlo sub-
populations by FACS.  These populations were then immediately subjected to the modified 
preplate process described previously.  The unsorted murine muscle derived cells did not 
undergo the same FACS process however.   The ALDHlo sub-population of cells not only 
suffered more cell death as a result of the FACS process, an observation made in many prior 
FACS isolations, but of those cells that survived adhered rapidly to collagen-coated flasks.  As 
depicted in Figure 41 (also depicted in Figure 17 in section 3.5.2) below, ALDHlo cells could 
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only be preplated for two iterations over a 2hr period (PP1 to PP2).  It should be noted that three 
cells were found in the fourth preplate following a thorough search of the entire T-75 flask, 
however this would hardly constitute a significant population especially given that no PP3 cells 
were observed.  On the other hand the ALDHhi subpopulation of muscle derived cells yielded a 
robust population of cells to preplate 4.  While the ALDHhi cell did not yield any cells to preplate 
6 (PP6) unlike the unsorted muscle derived cells, it should be born in mind that these cells were 
subjected to the high velocity mechanical stress of fluorescence activated cell sorting. 
 
Figure 41.  Preplate survival of ALDH sorted murine muscle derived cells 
Freshly dissociated murine skeletal muscle cells sorted into ALDHhi and ALDHlo sub-populations underwent the 
modified preplate process.  ALDHlo cells could only be preplated for two iterations over a 2hr period (PP1 to PP2). 
The ALDHhi subpopulation of muscle derived cells yielded a robust population of cells to preplate 4. 
 
We have initiated experiments on the spinner flask culture of murine muscle derived 
cells.  We have determined the spinner conditions to prevent myosphere, which we observed 
initially when the spinner culture was spun at very revolutions per minute (20 RPM).  To date we 
have observed good viability of cultured murine muscle derived cells for a period of 4 days in 
spinner culture.  Due to mechanical issues of the spinner plate, experiments had to be 
discontinued to date.  We will need proceed with experiments at longer spinner culture times to 
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determine if good viability can be achieved for longer time period and whether these culture 
conditions may enrich the cell population with MDSCs in a manner similar to the preplate 
technique. 
6.1.4 Discussion and future directions 
Two important conclusions can be drawn from the preplate experiment of ALDH sorted cells.   
The first is that ALDHhi cells have a greater propensity to survive the FACS process which is not 
surprising given their increased stress resistance in vitro and in vivo, observed in chapters 3 and 
4.  The second is that the ALDHhi population is enriched with cells that are slow to adhere a 
behavior that is similar to MDSCs.  This should not be surprising either given that MDSCs 
appear to be enriched with ALDHhi cells as seen in Figure 15. 
The spinner function is important to examine whether cells cultured in a spinner bottle 
that prevents adhesion will select for cells that are either ALDHhi, have stem cell like properties, 
have improved stress resistance, or improved muscular engraftment properties.  Of course, 
digested muscle will have numerous peripheral blood cells that may have a propensity to survive 
in the absence of an extracellular matrix, which is why I will need to verify the myogenic 
capacity of these cells.  Similarly, I have planned experiments to examine the survival rate of 
muscle derived cells sorted on the basis of ALDH activity in the spinner bottle environment. 
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6.2 MEASURING MUSCULAR VASCULARITY USING MICRO X-RAY 
TOMOGRAPHY 
6.2.1 Experimental design 
To qualify and quantify vascular changes in Ercc1 knock out mouse musculature, a murine 
model of progeria or accelerated aging289, I developed a method of muscle vasculature 
visualization in the mouse using polymer corrosion casting290,291.  Polymer casts can be scanned 
and digitally reconstructed using confocal as well as micro-computed tomography (microCT).  In 
this way we were able to quantify microvascular density in three dimensions (i.e. across an entire 
muscle), to quantify gross morphological changes as a function of age and Ercc1 activity. 
  Polymer perfusion methodology is described elsewhere290.  Briefly, the left ventricle 
was cannullated with a 24 gauge IV catheter and the right atrium is incised following 
thoracotomy.  Blood was flushed from the vasculature using 4ml Heparin/PBS (100 units/mL), 
4mL 10% Formalin, 4mL Heparin/PBS, followed by 3mL of polymer (Batson’s No. 17 
methylmethacrylate, Polysciences for confocal and SE microscopy or Microfil or FlowTech for 
microCT).  Casting solution was allowed to polymerize overnight at 4°C.  For confocal 
microscopy of  the tissue of interest, the gastrocnemius muscle in this case, was cryosectioned at 
40µm prior to imaging.  However for µCT imaging, the intact muscle can be imaged.  An intact 
cast of the vasculature was also obtained by allowing the tissue to be digested for 1 week in 10% 
NaOH, exchanged daily. 
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6.2.2 Results 
Perfusions were performed in wt mice as well as in Ercc1 -/∆ (20wks) were performed as seen in 
Figure 42 below.  A fluorescent Microfil polymer was used for confocal microscopy.  The 
confocal image was used to characterize capillary density in the gastrocnemius muscle.  A radio-
opaque Flotech polymer was used for µCT (micron scale computed tomography), which was 
used to reconstruct the vasculature of the intact gastrocnemius muscle. 
 
.  
Figure 42.  Radio-opaque polymer casting of skeletal muscle vasculature 
The intravascular volume or capillary density can quantified by perfusing the mouse with a 
fluorescent and radio-opaque polymer.  (a) Confocal microscopy was used to image capillaries in 
the gastrocnemius muscle.  (b)  µCT (micron scale computed tomography) was used to 
reconstruct the vasculature of the intact gastrocnemius muscle following perfusion. 
6.2.3 Discussion 
The methodology described here has been used extensively to perfuse murine central organs 
such as the lung and liver, however to my knowledge this has not been used in peripheral tissues 
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such as the gastrocnemius.  I worked closely with Donna Stolz and Atsu Nagao to quantify the 
capillary density and intravascular volume of the ERCC KO mouse, which was suspected to 
have decreased vascular density in its skeletal muscle.   Two limitations of this technique arose 
during the course of these experiments. The first is that due to the viscosity of the polymer, 
relatively high pressures are required to drive the polymer into the systemic vasculature of the 
mouse.  These high pressures have a propensity to rupture vessels in an unpredictable pattern.  
Therefore the technique does not always yield well perfused peripheral tissues suitable for 
imaging, however when the tissue is perfused properly, high quality confocal microscopy images 
can be obtained.  Gross intravascular pattern and volume characterization of intact tissues can be 
quickly obtained by µCT however the µCT machine the we use has a 10 µm resolution limit.  
Therefore capillaries are highly pixilated if they are detected at all.  Given the quality of the 
capillary images obtained by confocal microscopy, it appears that the lack of detection is not a 
matter of poor capillary perfusion rather it appears to be a µCT resolution issue.  There are 
however (non-synchrotron) µCT machines with practical resolution limits of 1µm, such as the 
Xradia MicroXCT. 
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